Active Smallcap & Microcap Investor
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Twin Trader Alerts for Friday, November 4, 2005 BIPH, IGPG, LLLI, IBAS
Dallas, Texas, Nov 04, 2005 (M2 PRESSWIRE via COMTEX) -- Twin Trader Alerts for Friday include Biophan Technologies (OTCBB: BIPH), Ignis Petroleum Group (OTCBB: IGPG), Lamperd Less Lethal Inc. (OTCBB: LLLI) and iBasis, Inc. (OTCBB: IBAS).
To feature your publicly traded company in our alerts, email feature@twintrader.com and we will gladly send more information on featuring your company with twintrader.com.
Biophan Technologies (OTCBB: BIPH) traded as much as .62% over open on Thursday.
Biophan Technologies a developer of next-generation biomedical technology announced recently that two U.S. Patents have issued to the Company, and one U.S. patent has issued to Nanoset, LLC, a technology collaborator which has granted Biophan exclusive worldwide medical rights. These newly issued patents increase the Company's intellectual property portfolio to 144 U.S. patents, licenses, or applications. In U.S. Patent 6,952,322, the Company teaches how to convert electrical information, including radio waves, into optical signals to move them along an optical fiber, when used in conjunction with MRI. U.S. Patent 6,925,328 covers cardiac assist devices made compatible with MRI, when MRI signals are detected, so that the communications circuit between the device and the heart can be interrupted, to avoid the potential dangers of tissue heating and induced voltages. U.S. Patent 6,930,242 covers virtually any medical conductor, including a pacemaker, defibrillator, or neurostimulator lead, that includes nanomagnetic coatings and is designed to be flexible.
Ignis Petroleum Group (OTCBB: IGPG) traded as much as .62% over open on Thursday.
Ignis Petroleum Group is a Dallas-based oil and gas company commencing its business plan for the exploration, acquisition and development of crude oil and natural gas properties in the U.S. Company management is focused on building an energy portfolio that benefits from the maturation of new petroleum technologies (in particular seismic interpretation) and the availability of short "outsteps" in the same play as previously-discovered hydrocarbons.
Lamperd Less Lethal Inc. (OTCBB: LLLI) traded as much as 6.67% over open on Thursday.
Lamperd Less Lethal Inc. announced recently that it entered into a Geographic Exclusive Commissioned Sales Agent Agreement with Tactical Operational Support Services LLC ("TOSS") dated effective August 2, 2005 pursuant to which TOSS will be Lamperd's sales agent in the Commonwealth of Puerto Rico and the Dominican Republic. TOSS will receive a base 20% commission on sales of Lamperd's products. The agreement has an initial 90 day term.
iBasis, Inc. (OTCBB: IBAS) traded as much as 1.02% over open on Thursday.
iBasis, Inc. a leader in international long distance, VoIP, and prepaid calling cards, today announced that Telefonica Deutschland GmbH, one of the largest independent IP carriers in Germany, has interconnected with iBasis to deliver comprehensive VoIP services to Internet service providers, other carriers and corporate customers. Using iBasis' DirectVoIP(TM) Broadband service, Telefonica has quickly established a direct IP interconnection with the iBasis global VoIP network in Germany which enables it to add competitive international calling to its IP Telephony offering without the large capital expense associated with fixed TDM circuits, local loops, digital cross-connect switches and gateway ports in global interconnect facilities and data centers.
About Twin Trader:
TwinTrader.com is committed to uncovering innovative and cutting-edge companies that are overlooked by the market. Our team of seasoned professionals actively work to find the best trading ideas each week. To receive our FREE reports as soon as they released, please subscribe to our member's list at: http://www.twintrader.com To feature your publicly traded company in our alerts, or to discuss our complete services, please contact: Scott or Reggie Sanchez at (469) 252-3034 or email feature@twintrader.com
Our services include our daily news releases. Additionally we produce comprehensive research reports on many publicly traded companies, do interviews with CEO's or other key executives, and we have a team of financial writers cover our companies.
Those interested may also email: feature@twintrader.com and we will gladly send more information on featuring your company with TwinTrader.com.
TwinTrader.com ("TT") provides its members with the latest news, press releases, and research reports for all the companies highlighted on the site. TT utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by TT to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. TT encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and TT makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. TT is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.twintrader.com or mentioned herein.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and TT undertakes no obligation to update such statements.
CONTACT: Scott or Reggie Sanchez, Publisher Tel: +1 214 227 7559 e-mail: feature@twintrader.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
(C)1994-2005 M2 COMMUNICATIONS LTD
Altert out on PTHO today. Take a look.
----------------------------------------
Subj: Company in the Spotlight
Date: 11/4/2005 6:41:55 A.M. Eastern Standard Time
From: carlisleva4475@aim.com
PTHO to Soar 600 Percent...
$12 Price Target on Huge News and
Record Breaking Contracts.
PTHO rated an “Urgent Buy” for aggressive investors must act quickly to accumulate a substantial position just before earth-shattering news is released that will send shockwaves through the core of the NanoTechnology industry.
Company: PSI-TEC HOLDINGS INC
Symbol: PTHO
Price 1.55
Shares Outstanding: 24 mill
Est Float: 2.6 mill
52 wk H/L : 5.45/.75
Rated: Urgent Buy
Outlook: Soaring Growth
Higher exchange listing anticipated near-term
PTHO Stock Breakout
Technically, PTHO has been trading in a very tight range around the $2.25 level. Increasing levels of broker and investor participation along with upcoming massive exposure will generate astounding upside movement, producing initial gains which could shoot the company back to it's year high of $5.45, then eclipsing this level on the way to double-digit territory.
Company Introduction
PSI-TEC Holdings, Inc. (OTC: PTHO) is an innovative, emerging leader engaged in the scientific development of highly advanced, next-generation Electro-Optic (EO) polymers. Speed, performance, and efficiency of their patented technologies place PTHO at the forefront of NanoTechnology, the world’s fastest growing industry.
Record Sales and Earnings
PTHO scores high marks as one of the very few “pure play” publicly traded NanoTech companies. Given their earning power and exponential revenue growth, standard analyst formulas would peg the stock at 5X to 7X its present valuation, even at a conservative P/E multiple.
PTHO has already received strong interest from leading technology companies in its core target markets of telecommunications, satellite, and aerial guidance / reconnaissance. Given the tremendous impact the Company’s polymers present for these markets, it is not unreasonable to envision a licensing agreement for use of PTHO’s technology that may very well exceed the $100 Million benchmark. We expect PTHO to conclude one or more lucrative licensing arrangements with major corporations over the near to intermediate term.
Escalated sales forecasts share a robust equivalency with the early, dramatic growth rates of Fortune 500 leaders in their heyday. Very seldom do you get perfection, yet this flawless, unknown gem has qualities resembling high- caliber Blue Chips that place it on a level that’s about as close as you can get.
Out of thousands of OTC companies we have reviewed, PTHO is the stock best qualified to earn the designation of Soaring Stock Pick! PTHO has hit its cruising speed, analytically viewed as a Company operating on a higher level. While approaching significant corporate milestones, we’re tuned into the cash-rich results of cascading growth nearly across the board.
Early investors must act quickly to avoid competing for shares as a flood of new buyers will imminently wake up and jump on board, leaving procrastinators to sit around wondering why they didn't buy PTHO when it was really cheap in September.
Certain information contained in these materials is "forward-looking" information, such as projections, estimates, pro formas, or statements of intentions, expectations or plans. All forward-looking information is subject to known and unknown risks and uncertainties, many of which are outside of the control of the company. Consequently, actual results may, and probably will, differ materially from the results contemplated in such forward-looking information. Stock Marketing Group, LLC was paid $1,000 for this advertisement. As with any company, nothing can ever be guaranteed, we simply give the facts and allow the investor to make a professional decision.
FONAR Sells Upright MRI Scanner to New Jersey Customer
MELVILLE, N.Y.--(BUSINESS WIRE)----FONAR Corporation (NASDAQ:FONR), The MRI Specialist(TM), announced today that it has sold its sixth Upright(TM) MRI in New Jersey. FONAR has sold its Upright(TM) MRI in 23 states and in four (4) international markets.
Raymond Damadian, M.D., president and founder of FONAR Corporation, "For strategic marketing and competitive reasons, the buyer has asked FONAR not to disclose either its name or the planned location of its new Upright MRI. This is not an unusual request and we will, of course, honor it. I can say, however, that the buyer has experience in managing MRI imaging centers and that this is its first Upright MRI purchase."
"The important thing for FONAR and its stockholders," continued Dr. Damadian, "is that Upright MRI is catching on. With more and more patients benefiting from the unique diagnostic information that only the Upright MRI can provide, and subsequently benefiting from better surgical results and treatment plans, patient demand for our product will continue to grow. In turn, of course, patient demand drives sales."
Dr. Damadian explained why the Upright MRI is able to provide diagnostic information that no other MRI can: "The Upright MRI is the only MRI that can scan patients in their normal everyday postures - sitting or standing. If a patient experiences lower back pain when he's standing, doesn't it make sense to be looking at that lumbar spine when he's standing? We're seeing case after case where the Upright MRI is finding pathology that conventional lie-down MRIs missed. The spine was designed to carry a full weight load. We think that its common sense that when a patient is complaining of back pain when he is vertical that you wouldn't want to lie him down and take pictures of his spine when that weight load has been removed."
Concerning the future of MRI, Dr. Damadian said, "I think it incorrect that anyone would seriously predict that the future of MRI will be confined to imaging patients lying still, and flat on their backs. The future of MRI must include the ability to scan any region of the body in any position, including weight-bearing positions, in which patients experience pain or other symptoms. MRI must be able to do dynamic imaging, including flexion and extension of the cervical and lumbar spines. These are of vital importance, and the Upright MRI is doing them right now! As one of our surgeon friends says, "If you can't see it, you can't fix it." The Upright MRI lets you see the problem where and when it can be seen! No other MRI can make that claim."
About FONAR:
FONAR was incorporated in 1978, making it the first, oldest and most experienced MRI manufacturer in the industry. FONAR introduced the world's first commercial MRI in 1980, and went public in 1981. Since its inception, the Company has installed over 300 MRI scanners worldwide. FONAR's stellar product line includes the Upright(TM) MRI (also known as the Stand-Up(TM) MRI), the only whole-body MRI that performs Position(TM) imaging (pMRI(TM)) and scans patients in numerous weight-bearing positions, i.e. standing, sitting, in flexion and extension, as well as the conventional lie-down position. The FONAR Upright(TM) MRI often sees the patient's problem that other scanners cannot because they are lie-down only. With over 100,000 patients scanned, the patient-friendly Upright(TM) MRI has a near zero claustrophobic rejection rate by patients. As a FONAR customer states, "If the patient is claustrophobic in this scanner, they'll be claustrophobic in my parking lot." Approximately 85% of patients are scanned sitting while they watch a 42" flat screen TV. The Company's latest MRI scanner is the FONAR 360(TM), a room-size recumbent scanner that optimizes openness while facilitating physician access to the patient. FONAR is headquartered on Long Island, New York, and has approximately 500 employees. Additional information may be found on the FONAR Web site at www.fonar.com.
MRI Specialist, Stand-Up, Upright, Position, PMRI and The Proof is in the Picture are trademarks of FONAR.
This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company's financial results may be found in the company filings with the Securities and Exchange Commission.
for FONAR
Daniel Culver, 631-694-2929 www.fonar.com
or Investor Relations: Darrow Associates, Inc.
Jordan M. Darrow, 631-367-1866 jdarrow@optonline.net
11/03/2005 07:00 ET
LLLI is getting significant buying again with a steady rise this week. Any positive news can easily send this stock flying much higher as we have seen before. Anyone with sell orders in place should make sure they are set well above the current trading price or they could be taken out in the first small percentage of a big move up. Even though things have taken longer to develop here than most people wanted, the potential in LLLI is as high as ever.
Vasomedical to Present at Rodman & Renshaw Techvest Seventh Annual Healthcare Conference
WESTBURY, N.Y., Nov 02, 2005 (BUSINESS WIRE) -- Vasomedical, Inc. ( VASO ), a leader in the noninvasive treatment and management of cardiovascular diseases, today announced that Thomas Glover, president and chief executive officer of Vasomedical, is scheduled to present at the upcoming Rodman & Renshaw Techvest Seventh Annual Healthcare Conference. The presentation is currently scheduled for 11:15 a.m. (Eastern Time) on Wednesday, November 9, 2005. The event will be held from November 7-9, 2005 at the New York Palace Hotel in New York.
Individuals may listen to a live web cast of the presentation by accessing the following link: http://wsw.com/webcast/rrshq7/vaso/ or by visiting the Company's web site at www.vasomedical.com, under the investor relations tab. The presentation will be archived for a limited time.
The conference will feature presentations from more than 290 public and privately held emerging growth healthcare companies presenting data on an array of therapeutic topics including oncology, cardiovascular diseases, central nervous system disorders, infectious diseases and medical device technologies. The conference aims to provide investors, both specialists and generalists, with the opportunity to meet with institutional investors, corporate executives and experts from the scientific and medical communities. The three-day conference will include company presentations, breakout sessions, Q&A, and one-on-one meetings with presenting companies. Details regarding the conference can be obtained at www.rodmanandrenshaw.com.
About EECP(R) Therapy
EECP external counterpulsation therapy is typically given in 35 one-hour sessions over seven weeks. Patients recline on a contoured treatment table and their calves, lower thighs and upper thighs are wrapped in a pneumatic cuff set. The system, which is synchronized to the individual patient's cardiac cycle, inflates the cuffs with air to create external pressure when the heart is resting and deflates the cuffs just before the next heartbeat. The system's action, which pulses counter to the heart's beating, increases blood flow to the heart muscle and other organs and decreases the heart's workload, creating a greater oxygen supply for the heart muscle while lowering its need for oxygen.
About Vasomedical, Inc.
Vasomedical, Inc. is primarily engaged in designing, manufacturing, marketing and supporting EECP external counterpulsation systems based on the Company's unique proprietary technology. EECP therapy is a noninvasive, outpatient therapy for the treatment of diseases of the cardiovascular system currently indicated for use in cases of stable or unstable angina, congestive heart failure, acute myocardial infarction and cardiogenic shock. The therapy serves to increase circulation in areas of the heart with less than adequate blood supply and may restore systemic vascular function. The Company provides hospitals, clinics and private practices with EECP equipment, treatment guidance and a staff training and equipment maintenance program designed to provide optimal patient outcomes. Additional information is available on the Company's website at http://www.vasomedical.com.
EECP is a registered trademark for Vasomedical's enhanced external counterpulsation systems.
Except for historical information contained in this release, the matters discussed are forward-looking statements that involve risks and uncertainties. When used in this report, words such as "anticipated," "believes," "could," "estimates," "expects," "may," "plans," "potential" and "intends" and similar expressions, as they relate to the Company or its management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Among the factors that could cause actual results to differ materially are the following: the effect of the dramatic changes taking place in the healthcare environment; the impact of competitive procedures and products and their pricing; medical insurance reimbursement policies; unexpected manufacturing or supplier problems; unforeseen difficulties and delays in product development programs; the actions of regulatory authorities and third-party payers in the United States and overseas; uncertainties about the acceptance of a novel therapeutic modality by the medical community; and the risk factors reported from time to time in the Company's SEC reports. The Company undertakes no obligation to update forward-looking statements as a result of future events or developments.
SOURCE: Vasomedical, Inc.
Vasomedical, Inc.
Thomas W. Fry, 516/997-4600
investorrelations@vasomedical.com
or
Investor Relations:
Lippert/Heilshorn & Associates, Inc.
Kim Golodetz, 212/838-3777
kgolodetz@lhai.com
or Bruce Voss, 310/691-7100
bvoss@lhai.com
Copyright Business Wire 2005
Sony Teams up with FONAR to Deliver ``Upright'' MRI Solutions; Sony FilmStation System's Vertical Install Capability a Perfect Complement to the FONAR Upright(TM) MRI System
MELVILLE, N.Y.--(BUSINESS WIRE)----FONAR Corporation (NASDAQ:FONR), The MRI specialist(TM), announced today the signing of an agreement with Sony Electronics to resell the Sony FilmStation(TM) 14 x 17-inch dry film imager as a first ever, exclusive film imager offering to its customers. The deal expands FONAR's product portfolio, enabling the Company to provide an output solution which is particularly well suited for its Upright(TM) MRI.
"Sony is excited to add FONAR to its roster of OEMs," said Steven Blum, vice president of medical systems at Sony Electronics. "We are pleased that FONAR has selected the FilmStation to be its dry film imager offering. FONAR's reputation as a leading manufacturer of MRI scanners enhances the reputation of the Sony FilmStation system as the dry imager of choice among medical professionals."
For 25 years, FONAR has been on the leading edge of innovation in the MRI industry. In 1980, FONAR revolutionized diagnostic imaging through the introduction of the world's first commercial MRI scanner. The Upright(TM) MRI is billed as 'the world's first truly "open" MRI', allowing patients to walk in, sit or stand during scans, and providing patients comfort due to an unobstructed view. For added flexibility, it is the only whole-body MRI that performs Position(TM) imaging where patients can be scanned in various positions of flexion, extension, rotation and lateral bending as well as the conventional lie-down position. The Upright(TM) MRI's vertical disposition makes it seamlessly compatible with the Sony FilmStation imager.
The Sony FilmStation 14 x 17-inch dry film imager is the only imager of its kind that can be installed either in the upright vertical position or horizontally. It outputs film in less than one minute, and when connected with another FilmStation imager it prints up to 130 films per hour. The FilmStation system features high-resolution 320-dpi thermal head technology and automatic calibration for high-image quality. The Sony FilmStation imager's vertical install capability is a perfect complement to the FONAR Upright(TM) MRI system.
"We are very pleased to team up with Sony, a pronounced leader in the medical imaging market. In reviewing the various imager solutions on the market, we ultimately selected the FilmStation due to its outstanding reputation for quality, reliability, versatility and value. Leveraging the FilmStation imager with FONAR's stellar MRI systems will lend both ourselves and Sony the advantage of staying ahead of the technological curve in the ever-changing medical landscape," said Raymond V. Damadian, president and founder of FONAR.
The announcement by Sony Electronics may be found on their Web site at: http://news.sel.sony.com/pressrelease/6252.
About Sony Electronics Inc.
Sony Electronics Inc. is a leading provider of innovative medical products through Sony Medical Systems. Sony medical products are designed for use in a wide range of applications as stand-alone hardware or for incorporation into integrated medical systems. Medical imaging offerings include dry film imagers, printers and medical grade monitors for a full range of modalities. For more information call 1-800-535-SONY or visit www.sony.com/medical.
About FONAR
FONAR was incorporated in 1978, making it the first, oldest and most experienced MRI manufacturer in the industry. FONAR introduced the world's first commercial MRI in 1980, and went public in 1981. Since its inception, the Company has installed over 300 MRI scanners worldwide. FONAR's stellar product line includes the Upright(TM) MRI (also known as the Stand-Up(TM) MRI), the only whole-body MRI that performs Position(TM) imaging (pMRI(TM)) and scans patients in numerous weight-bearing positions, i.e. standing, sitting, in flexion and extension, as well as the conventional lie-down position. The FONAR Upright(TM) MRI often sees the patient's problem that other scanners cannot because they are lie-down only. With over 100,000 patients scanned, the patient-friendly Upright(TM) MRI has a near zero claustrophobic rejection rate by patients. As a FONAR customer states, "If the patient is claustrophobic in this scanner, they'll be claustrophobic in my parking lot." Approximately 85% of patients are scanned sitting while they watch a 42" flat screen TV. The Company's latest MRI scanner is the FONAR 360(TM), a room-size recumbent scanner that optimizes openness while facilitating physician access to the patient. FONAR is headquartered on Long Island, New York, and has approximately 500 employees. Additional information may be found on the FONAR Web site at www.fonar.com.
MRI Specialist, Stand-Up, Upright, Position, PMRI and The Proof is in the Picture are trademarks of FONAR.
This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company's financial results may be found in the company filings with the Securities and Exchange Commission.
FONAR Daniel Culver, 631-694-2929 www.fonar.com OR Investor Relations: Darrow Associates, Inc. Jordan M. Darrow, 631-367-1866 jdarrow@optonline.net
11/02/2005 07:00 ET
Bellwether Report is currently following Vasomedical Inc.
Oct 26, 2005 (M2 PRESSWIRE via COMTEX) -- Today the Bellwether Report has identified Vasomedical Inc. (Nasdaq:VASO), a company that our analysts will be tracking over the ensuing weeks. They recently came out with a significant corporate development this month, causing a positive correction. For a full report on the below mentioned company, and many more, feel free to visit http://www.bellwetherreport.com for a free 30 day no obligation trial.
This company has been struggling for quite some time now. Back in May/05 Vasomedical commenced with restructuring , including workforce reduction & tightening the spending. The company had a challenging year as sales declined from year 2004. Total revenues for fiscal 2005 were $15.1 million compared with $22.2 million for the 12 months of fiscal 2004. Net loss for the 12 months ended May 31, 2005 was $5.6million compared with a net loss of $3.4 million for 12 months ended May 31, 2004. Cash & cash equivalents & certificates of deposits at May 31, 2005 were $2.7 million compared with $7.5 million at May 31, 2004.
Yesterday October 25/05 Vasomedical Inc.filed a form 8-K revealing that the company was informed that the report of the PEECH Clinical Study has been accepted for publication in a major peer-reviewed medical journal. The journal requires that the contents of the report be held confidential until its publication. Therefore, no additional information concerning this article will be provided until such time as it is published. We shall look forward to the publication and hopefully it will be a catalyst to generate some positive kharma for Vasomedical.
Vasomedical, Inc. engages in.....
To view the full unbiased report on Vasomedical Inc. (Nasdaq:VASO), feel free to visit our site. This article and many more are available for review under the Today's Articles Section. No credit Card Needed!!
The Bellwether Report will continue scanning the markets for true emerging growth opportunities that will show subscribers optimal entry points with profitable exit points. If you are interested in receiving more information on feel free to sign up for a 1 month complimentary subscription to the #1 online investment resource www.bellwetherreport.com.
All material herein was prepared by the Bellwetherreport.com, (Bellwether) based upon information believed to be reliable. The information contained herein is not guaranteed by Bellwether to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Bellwether is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. Bellwether may receive compensation in cash or shares from independent third parties or from the companies mentioned.
Bellwether's affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Jay Lee.
Bellwether will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and Bellwether undertakes no obligation to update such statements.
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
(C)1994-2005 M2 COMMUNICATIONS LTD
PSI-TEC Attracts Seasoned Lucent/Bell Labs Modulator Expert Dr. Gray D. Blake
Industry Expert Will Guide Material Development Through Final Testing Phase; Company Developing EO Polymers for High-Speed Internet, Satellite and Military Applications
WILMINGTON, Del., Oct 31, 2005 (BUSINESS WIRE) -- PSI-TEC Corp., a wholly owned subsidiary of PSI-TEC Holdings Inc. (Pink Sheets:PTHO), a technology-based company developing chemical-based (polymer) materials for a wide roster of broadband telecommunication and military applications, announced today that it has engaged the consultancy services of former Lucent and Bell Labs veteran Dr. Gary D. Blake. PSI-TEC scientists and management expect Dr. Blake's extensive experience in modular technology to greatly accelerate the development and commercialization of PSI-TEC's breakthrough material designs.
PSI-TEC's molecularly-engineered materials are the basis of the company's revolutionary electro-optic technology product strategies. The resolution of the stability issue in material design, together with an exceptional R33 EO coefficient and high-yield material synthesis process, represents the potential to remove the final hurdle to the broad proliferation of low-cost EO polymers for numerous high-speed Internet, telecom, satellite and military applications.
"Dr. Blake's unique background and experience with modulator technology, together with his superb project management skills, is an ideal match for our emerging needs," stated Ron Genova, interim CEO of PSI-TEC Corp. "As it is imperative that we provide solid, credible performance data on our revolutionary nanotechnology-engineered EO polymer materials, we have reached the point where the collection and processing of test data must be performed using only the highest of industry-recognized practices and conditions. Dr. Blake's extensive expertise in this area will guide the project from testing to reporting and production in the coming months."
Dr. Blake's most recent accomplishments come from Lucent Technologies/Bell Labs where he supervised the design, fabrication, testing, qualification and production ramp of Lucent's highly successful lithium niobate modulator technology platform.
"Drawing on his proven success with test requirements, equipment, procedures and practices, Dr. Blake will work closely with Dr. C.C. Teng, PSI-TEC's distinguished member of technical staff, to establish testing facilities for material evaluations," said Frederick Goetz, Jr., president of PSI-TEC Corp. "The collaborative test facility effort by Dr. Blake and Dr. Teng is critical to confirming the soundness of our Aromatic Gain theory approach and will play an instrumental role in the future development and testing of waveguides, high-speed Mach-Zehnder modulators, and other devices created from our OE polymer material platform."
Company sources believe mu-beta and initial R33 EO coefficient test data (figures of merit for high-speed non-linear optic NLO polymer performance) could be released before the end of this year on the company's first commercial nanotechnology-engineered EO polymer molecule. The company projects definitive material stability testing will be completed shortly thereafter on waveguide structures.
About PSI-TEC
PSI-TEC Corp. is a developmental stage company that engineers next-generation electro-optic (EO) plastics for future applications vital to modern commerce, homeland security and medical technology. PSI-TEC's proprietary electro-optic plastics are produced at the molecular level for superior performance, stability and cost-efficiency and are expected to replace more expensive, lower-performance materials used in fiber-optic ground, wireless and satellite communication networks. For more information regarding PSI-TEC's mission, management and technology, visit the company at www.psiteccorp.com.
Safe Harbor Statement
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, and various other factors beyond the company's control.
SOURCE: PSI-TEC Corp.
Thinkbig Media for PSI-TEC Corp.
Carrie Altuvilla, 949-330-6055
Mobile: 661-312-6952
carrie@thinkbigmedia.com
Copyright Business Wire 2005
Petrogen Spuds Tiller Ranch #1 Well
- Plans for 6 Well Drilling Program Commence on Newly Acquired Texas Gulf Coast Property -
HOUSTON, Oct 31, 2005 /PRNewswire-FirstCall via COMTEX/ -- Petrogen Corp. ( PTGC ), announced today that on October 29th, 2005, the Tiller Ranch # 1 well (the "TR#1") was spudded, the first well in a drilling program which marks the beginning of Petrogen's Texas Gulf Coast operations winter drilling season initiative.
The Company's Tiller Ranch Field lease (the "Lease") is located within Tom Graham Field, Jim Wells County, Texas, which has produced over thirteen billion cubic feet of natural gas (13 Bcfg) from twenty-five distinct sands as well as six million eight hundred thousand barrels of oil (6.8 Mmbo) from six sands. Extensive subsurface control, provided by approximately twenty-five wells located on or adjacent to the Lease, indicate that potentially up to 18 Bcfe of natural gas reserves could be recovered through the development of up to six new wells, which the Company plans to complete during Q4-2005 through to Q2-2006.
On October 13th, 2005 the Company's field crew staked the location for the TR#1 and commenced location preparations as well as installation of the various support infrastructure necessary for the drilling program. On October 27th, 2005, Nopolitas Drilling, LP's drilling rig was mobilized to location and the TR#1 was spud shortly thereafter. The Company anticipates that the TR#1 will take 10 days to drill to a depth of approximately 6,000 feet, targeting the upper Vicksburg and Frio gas-bearing formations. Subsequently, an extensive testing and completion program is expected to be implemented. Five additional locations on the Lease have been mapped to follow the potential successful drilling and evaluation of the TR#1.
Petrogen's Chairman and CEO, Sacha H. Spindler stated, "We're very pleased to start developments at Tiller Ranch. The property provides for an excellent potential follow-on natural gas discovery opportunity and development platform to our other recent successes in the Texas Gulf Coast, which could significantly extend our current operations."
The Lease consists of potential natural gas exploitation opportunities trapped along a north-south striking, underdeveloped, low relief anticline. Eight previously producing wells were drilled and produced on the Lease during the 1940's and 1950's when local natural gas prices were in the $0.02 -- $0.10 per Mcf range, resulting in limited exploitation of the natural gas reserves on the Lease due to the sub-economic take away prices. However, wells in the area have average production histories of approximately eight to ten years with cumulative production of approximately 3.0 Bcfg per well, which could provide for substantial increases in Petrogen's natural gas reserves and daily production.
Extensive natural gas gathering infrastructure exists within the area providing for immediate transportation and sales of any potential upcoming natural gas production anticipated from the drilling program. Current gas prices for potential production from the Tiller Ranch area are in the $11.00 -- $11.50 per Mcf range and will be sold into the Enterprise Products Partners natural gas pipeline system in South Texas.
Mr. Spindler further stated, "Tiller Ranch is another example of the caliber of opportunities Petrogen strives to develop in the Texas Gulf Coast. It possesses significant geologic data and well control along proven hydrocarbon-producing trends that enables the Company to greatly reduce its geologic risk while increasing its degree of confidence that the 18 billion cubic feet of indicated potential reserves could be readily exploited through our current drilling initiatives."
About The Texas Gulf Coast
Texas and the Texas Gulf Coast represent one of the premier natural gas exploration and development regions in the world, accounting for 32% of all natural gas production and 27% of proved natural gas reserves in the United States. Over the past few years, several large discoveries by Shell, BP and Chevron Texaco have contributed to the growing prominence of the Gulf Coast region as a hotbed for the expansion of domestic natural gas developments.
About Petrogen
Petrogen Corp. is a Houston, Texas based upstream energy company specializing in the development of natural gas properties in the Texas Gulf Coast region with known hydrocarbon reserves. For further information, please visit the Company's website at http://www.petrogencorp.com.
THIS NEWS RELEASE MAY INCLUDE FORWARD-LOOKING STATEMENTS WITHIN THE MEANING OF SECTION 27A OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, AND SECTION 21E OF THE UNITED STATES SECURITIES AND EXCHANGE ACT OF 1934, AS AMENDED, WITH RESPECT TO ACHIEVING CORPORATE OBJECTIVES, DEVELOPING ADDITIONAL PROJECT INTERESTS, THE COMPANY'S ANALYSIS OF OPPORTUNITIES IN THE ACQUISITION AND DEVELOPMENT OF VARIOUS PROJECT INTERESTS AND CERTAIN OTHER MATTERS. THESE STATEMENTS ARE MADE UNDER THE "SAFE HARBOR" PROVISIONS OF THE UNITED STATES PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 AND INVOLVE RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE IN THE FORWARD-LOOKING STATEMENTS CONTAINED HEREIN.
Company Contact
Louis J. Fruchier
V.P. Corporate Development & Communications
Petrogen Corp.
888-875-1155
fruchier@petrogencorp.com
SOURCE Petrogen Corp.
Louis J. Fruchier, V.P. Corporate Development & Communications, of Petrogen
Corp., 1-888-875-1155, fruchier@petrogencorp.com
http://www.prnewswire.com
Copyright (C) 2005 PR Newswire. All rights reserved.
Yes, the buying continued again today. See the chart:
http://finance.yahoo.com/q/bc?s=INCA.OB&t=5d
Veridien Corporation Receives EPA Label Approval For Hepatitis A, B and C Kill Claims on Disinfectant Towelettes
ST. PETERSBURG, Fla., Oct 27, 2005 (BUSINESS WIRE) -- Veridien Corporation ( VRDE ):
-- The Patented Viraguard(R) Formula is the Only EPA Approved Disinfectant With Hepatitis A, B and C Label Claims That Is Also Drug Listed By the FDA As A Hand Antiseptic;
-- CDC estimates that 4.95 million Americans suffer from chronic hepatitis infections
Veridien Corporation ( VRDE ) announced today that the Viraguard(R) Hospital Hard Surface Disinfectant Towelettes have received stamped EPA approval for killing Hepatitis A, B and C viruses. These approvals now clearly distinguish the Viraguard(R) Disinfectant Towelettes as one of the premiere disinfecting wipes in the healthcare industry. Only Viraguard(R) Disinfectant Towelettes are authorized to make label claims about its effectiveness against all three Hepatitis viruses (A, B and C). The patented Viraguard(R) formula is the only EPA approved disinfectant with Hepatitis A, B and C label claims that is also drug listed by the FDA as a hand antiseptic.
According to the US Centers for Disease Control ("CDC"), the average rate of infections annually for hepatitis A, B and C is over 160,000 cases per year. As well, the CDC estimates that the number of Americans with chronic hepatitis infections exceeds 4.95 million people. ( www.cdc.gov/ncidod/diseases/hepatitis/resource/dz_burden02.htm)
In addition to the Hepatitis A, B and C kill claims, the Viraguard(R) Disinfectant Towelettes now carry all the viral and bacterial kill claims of the Viraguard(R) liquid disinfectants, including Methicillin-resistant Staphylococcus Aureus (MRSA), Vancomycin-resistant Enterococcus Faecalis (VRE), Herpes Simplex-type 1 and 2, Escheria coli (E.coli) strain 157, Mycobacterium bovis (BCG, TB surrogate), Pseudomonas aeruginosa, Streptococcus Pyogenes, Salmonella choleraesius, Staphylococcus aureus, Respiratory syncytial virus (RSV), Rotavirus (SA-11 Group A), Influenza Hong Kong type 1 and 2, HIV-1 (aids virus), Trichophyton mentagrophytes (athlete's foot fungus), Cytomegalovirus (CMV) and Adenovirus Type 2.
Paul Dunnigan, VP-Marketing Group, "This is outstanding news for our healthcare, industrial and retail clientele. With the new EPA approved label claims, Viraguard(R) Infection Control Products provide our customers with the full Hepatitis and anti-viral protection they need in surface disinfecting wipes as well as in liquid disinfectants. We offer them equal protection for hand sanitizing by using the same tested, safe and effective formula in our hand antiseptic products. In particular, Veridien's products are critical in helping to control orally transmitted pathogens (Hepatitis A) and blood-borne pathogens (Hepatitis C) that threaten food workers, emergency medical workers, clinicians and physicians worldwide. Veridien's strategic multi-national client and distributors regard the anti-viral kill claims as a distinct advantage to leverage large contracts in the health and safety industry."
Jeff Selph, Chief Scientific Officer of Veridien, said, "We live in a highly infected world. Numerous outbreaks of Hepatitis and other viruses are driving the need for products with superior kill claims. Healthcare and industrial professionals can depend on Viraguard(R) Infection Control Products to help minimize many of the risks."
Viraguard(R) Infection Control products are available to healthcare practitioners and industrial materials managers through major distributors across the United States. Viraguard(R) Products can also be purchased for use at home or at the office at www.buyveridien.com.
For more information about Veridien Corporation, A Life Sciences Company, its products and investments in future technology, go to:
http://www.veridien.com
and
http://www.mycosol.com
Special Note: Forward-looking statements in this press release (identifiable by such words as "believes","expects") are made pursuant to the "safe-harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, market acceptance of, and demand for, the Company's products, manufacturing, development and distributor issues, product pricing, competition, funding availability, technological changes, and other risks not identified herein. The Company disclaims any intent or obligation to update any forward-looking statements.
SOURCE: Veridien Corporation
Veridien Corporation, Pinellas Park
Cheryl Ballou, 727-576-1600
cballou@veridien.com
Copyright Business Wire 2005
Law Enforcement Associates Retains Pfeiffer High Investor Relations to Implement National Investor Relations Campaign
YOUNGSVILLE, N.C., Oct 27, 2005 /PRNewswire-FirstCall via COMTEX/ -- Law Enforcement Associates Corporation (LEA) ( AID ), a leading provider of surveillance and security technologies to the global law enforcement, military, security and corrections markets, today announced it has retained Pfeiffer High Investor Relations, Inc., to develop and implement a national investor relations program.
Paul Feldman, president of LEA, said, "Worldwide demand for sophisticated security and surveillance equipment continues to expand, and LEA is benefiting from these market conditions. Given the continued improvements in our financial performance and our optimism about the company's long-range growth prospects, we believe it is appropriate to proactively communicate our story to the investment community and financial media. Pfeiffer High has more than two decades of investor relations experience and has represented some of the leading emerging growth companies in the country. We were impressed by the firm's professional approach and look forward to leveraging Pfeiffer High's experience and relationships within the financial community."
Geoff High, a principal of Pfeiffer High, said, "LEA and its respected AID division are prominent players in an increasingly important industry. Our objective is to implement a proactive and strategic communications program that expands LEA's audience among buy- and sell-side investors and analysts. Considering the worldwide focus on issues of security and intelligence, we believe the LEA story is one that will resonate with select investment audiences."
About Law Enforcement Associates, Inc. (LEA)
LEA is a leading security and surveillance technology company that manufactures and markets a diverse product line to the worldwide law enforcement, military, security and corrections markets. The company's Audio Intelligence Devices (AID) division has been serving the law enforcement sector for more than 30 years and is one of the most respected names in the surveillance equipment industry. LEA's products are used by a wide variety of government and non-governmental agencies, as well as public and private companies. These include military bases, nuclear facilities, embassies, government installations, oil refineries, United Nations and NATO locations. LEA's products also have been used at high-profile events such as the Summer & Winter Olympics, Super Bowl, U.S. Golf Championship, and the Democratic and Republican National Conventions. Its products include the Under Vehicle Inspection System (UVIS), EDK123 (Explosive Detection Kit), Bloodhound GPS Tracking System, Letter-bomb Visualizer Spray, and a wide variety of Audio & Video Surveillance Equipment. Headquartered in Youngsville, N.C., the Company has been featured in many industry publications and websites. For more information, please visit www.leacorp.com.
About Pfeiffer High Investor Relations, Inc.
Based in Denver, Pfeiffer High Investor Relations is a full-service investor relations firm providing a broad range of investor relations and corporate communications services to publicly held companies. Founded in 1982, the firm specializes in creating and implementing communications programs for companies seeking to build shareholder value by increasing their profiles in the investment community and financial media. Pfeiffer High represents a select group of companies listed on the major U.S. exchanges. A sampling of current clients includes Dynamic Materials Corporation, the world's leading provider of explosion-welded clad metal plates; Peerless Systems, a provider of imaging and networking controllers to the digital document market; Evolving Systems, a premier provider of software solutions and services to major telecommunications carriers; and Tipperary Corporation, an independent oil and gas company.
Forward-Looking Information:
The statements in this news release contain forward-looking information within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve certain risks, assumptions and uncertainties, including the inability to generate and secure the necessary product sales, or the lack of acceptance of the company's products by its customers. In each case actual results may differ materially from such forward-looking statements. The company does not undertake to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results (expressed or modified) will not be realized.
SOURCE Law Enforcement Associates, Inc.
Geoff High of Pfeiffer High Investor Relations, Inc., +1-303-393-7044, for Law
Enforcement Associates, Inc.
http://www.prnewswire.com
Copyright (C) 2005 PR Newswire. All rights reserved.
Update from the President: Bulldog Poised to Move Forward with Unique Security Products
RICHMOND, British Columbia, Oct 27, 2005 (BUSINESS WIRE) -- Bulldog Technologies Inc. ( BLLD ) is a designer and manufacturer of wireless security solutions and sensor networks that monitor and secure valuable cargo in the global supply chain. Our solutions use advanced wireless technologies and easy to use web-based software to track, monitor and secure goods in transit, stored in distribution centers, in ports or holding yards. Our initial focus is to penetrate the pharmaceutical and high tech markets that transport high value goods.
During the past three months, Bulldog Technologies has grown in leaps and bounds. When a company launches several new products into the market, there are always going to be major challenges to overcome and Bulldog is now poised to move forward with some very unique security products.
Listed below are major areas of progress Bulldog Technologies has made in the past three months.
1. CORPORATE
In September, Bulldog's MiniBOSS(TM) was nominated by Kyocera wireless for Qualcomm's prestigious CDMA 3G A-List Award for Innovation. The A-List Awards are awarded to various technology developers for their work with enterprise wireless data solutions and services.
Chosen from forty nominees, Bulldog was the proud recipient of the Richmond's (BC) Chamber of Commerce Business Excellence Award on October 18, 2005.
Bulldog Technologies Mexico Inc. is now incorporated in Sinaloa, Mexico.
Effective September 2005, a new service and shipping facility has been opened in Bellingham, Washington.
Facility Expansion
Bulldog has now completed the software for MiniBOSS(TM) product, allowing customers to track their goods via the internet while protecting the client's PC firewall.
Staff
Bulldog staff has been increased by six personnel including an Office Manager, Inside Sales personnel, three Engineers and Manager of Operations. Two additional sales personnel are scheduled to join the team as of November 1, 2005.
2. ENGINEERING
Patents
Existing North American patent protection has now been extended worldwide for RoadBOSS(TM), YardBOSS(TM) and TankerBOSS(TM).
New Product Designs
During the past three months, Bulldog has designed new housings for the RoadBOSS(TM) and YardBOSS(TM). The new design allows the unit to fit between the rear locking rods of a container or tractor trailer, thus preventing the unit from being damaged. At the same time, Bulldog has changed the housing to be virtually indestructible and has cut assembly costs by 50%.
Technical Changes
The RoadBOSS(TM) now houses its own tracking device and does not have to rely upon a tracking system within the vehicle to operate. This enables a container to be protected if left parked. With the security and tracking all in one unit, there is no need for the truck to have GPS tracking capabilities thus cutting the cost by up to $1,500. Ultimately, all that is needed is the one unit at a cost of $1,200. We anticipate that manufacturing of this unit will commence November 1, 2005.
3. SALES AND MARKETING
Over the past three months, Bulldog has successfully completed 11 pilots in total: 8 with the MiniBOSS(TM), 2 with the YardBOSS(TM) and 1 with the RoadBOSS(TM). These trials have provided Bulldog with real experience as to how companies will implement the BOSS(TM) products and also allow for modifications to be made to the software platform. The recently designed software allows a client to monitor cargo movement through a web based application. Clients that will use the MiniBOSS(TM), RoadBOSS(TM), and TankerBOSS(TM) units will enter into an airtime agreement thus giving Bulldog ongoing monthly revenues.
In addition, over the past 2 months Bulldog has participated in meetings with FedEx and UPS to discuss implementation of our MiniBOSS(TM) product.
Overseas Markets
Bulldog is aggressively seeking opportunities in countries outside North America. The RoadBOSS(TM) unit was been successfully piloted in Costa Rica and Bulldog has also been contacted by companies in Argentina, Brazil, Africa, Lebanon, France and the Middle East.
Mexico Update
In October, Bulldog's VP of Engineering, VP of Sales & Marketing and I were invited to Mexico City by the Mexican Business Council for Foreign Trade, Investment and Technology (COMCE). A meeting was arranged with Ney Villamil Ruiz, CEO of COMCE and twenty two senior executives of some of the largest trucking fleets in Mexico. Our products were received with great enthusiasm with several companies requesting pilots as soon as can be arranged.
Meetings with heads of Mexico's ports and customs for Mexico expressed great interest in our product and have requested a port pilot immediately. Pemex, Mexico's only company authorized to extract, produce and market liquid natural gas has also requested a pilot as soon as possible.
A meeting is scheduled for June 2006 with President Vincente Fox to further Bulldog's alliance with the Mexican market.
Existing Contracts
Barnes & Noble, Argix and Ruan Transportation have begun taking delivery of their MiniBOSS(TM) units and RFID systems.
SUMMARY
Bulldog has faced many challenges and is now beginning a new era. We are making great advancements as we introduce some of the best security devices.
Theft of full container loads of cargo has escalated dramatically in the last few years. Organized theft rings have discovered the profitability of stealing trailer loads of goods and reintroducing them back into the global supply chain. Recent estimates by law enforcement agencies indicate the theft of cargo container goods in the United States to be approximately $10 billion. Globally, this number is estimated in the $100 billion range. Additionally, many losses go unreported so the actual loss may be significantly higher.
Bulldog Technologies is dedicated to providing products to combat this growing problem. Using our advanced wireless security technologies, manufacturers and shippers of goods can reduce losses and ensure the delivery of valuable cargo.
Thank you for your continued support.
John Cockburn
President and CEO
About Bulldog Technologies
Bulldog has developed a line of wireless security products targeted at combating theft in the retail supply chain, from leakage to pilferage to cargo container theft. As experts in wireless security solutions, we offer solutions ranging from RFID to long range wireless devices focused on securing valuable retail items in storage or in transit.
For further information, visit Bulldog on the Web at http://www.bulldog-tech.com.
SOURCE: Bulldog Technologies Inc.
Bulldog Technologies Inc.
Jan Roscovich, 604-271-8656
jroscovich@bulldog-tech.com
Copyright Business Wire 2005
Significant buying started yesterday and continued through today. See this chart:
http://finance.yahoo.com/q/bc?s=INCA.OB&t=5d
Looks like some good news is on the wind for INCA. Be careful not to sell any shares too soon. This stock could triple or more very quickly.
Keep your eyes open for more PRs on the plans now being put into effect for the future.
Note: Another dividend has now been declared for HQNT shareholders (looks like the largest one to date, as a matter of fact). HQNT shareholders should keep in mind that selling any HQNT shares too soon can disqualify them from receiving shares in this dividend distribution.
Form 8-K for VASOMEDICAL INC
-------------------------------
25-Oct-2005
Other Events
Item 8.01 Other Events
The Company has been informed that the report of the PEECH Clinical Study has been accepted for publication in a major peer-reviewed medical journal. The journal requires that the contents of the report be held confidential until its publication. Therefore, no additional information concerning this article will be provided until such time as it is published.
H-Quotient Agrees to Sell Manufacturing Division
HOUSTON, TX--(MARKET WIRE)--Oct 25, 2005 -- H-Quotient, Inc., (Other OTC:HQNT.PK - News) announced completion of negotiations to sell its medical manufacturing subsidiary, Stewart & Shaw Inc., to Standard Holdings Group Ltd. (Other OTC:SNDH.PK - News) for consideration, including 26 million shares of SNDH stock. This includes 6 million shares already received, most of which was distributed to H-Quotient shareholders as a dividend. A portion of the remaining 20 million shares will soon be distributed to HQNT stockholders. Attorneys for the two companies conducted the negotiations.
HQNT purchased the subsidiary last year.
HQNT will focus its efforts on the Company's core software business. SNDH plans to pursue diverse business opportunities.
This announcement may contain, in addition to historical information, certain forward-looking statements that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.
For more information visit the H-Quotient web site at http://www.hquotient.com.
Contact:
H-Quotient, Inc.
(713) 960-9900
------------------------------------------
Source: H-Quotient, Inc.
H-Quotient Agrees to Sell Manufacturing Division
HOUSTON, TX--(MARKET WIRE)--Oct 25, 2005 -- H-Quotient, Inc., (Other OTC:HQNT.PK - News) announced completion of negotiations to sell its medical manufacturing subsidiary, Stewart & Shaw Inc., to Standard Holdings Group Ltd. (Other OTC:SNDH.PK - News) for consideration, including 26 million shares of SNDH stock. This includes 6 million shares already received, most of which was distributed to H-Quotient shareholders as a dividend. A portion of the remaining 20 million shares will soon be distributed to HQNT stockholders. Attorneys for the two companies conducted the negotiations.
HQNT purchased the subsidiary last year.
HQNT will focus its efforts on the Company's core software business. SNDH plans to pursue diverse business opportunities.
This announcement may contain, in addition to historical information, certain forward-looking statements that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.
For more information visit the H-Quotient web site at http://www.hquotient.com.
Contact:
H-Quotient, Inc.
(713) 960-9900
------------------------------------------
Source: H-Quotient, Inc.
European Institute of Oncology Receives CT Laser Breast Imaging System
Sixth CT Laser Mammography System in Italy
FORT LAUDERDALE, Fla., Oct 24, 2005 /PRNewswire-FirstCall via COMTEX/ -- Imaging Diagnostic Systems, Inc., ( IMDS ) announced today that a CT Laser Mammography (CTLM(R)) system will be installed at the prestigious European Institute of Oncology (EIO) in Milan, Italy. Studies will be performed under the auspices of Professor Umberto Veronesi, Scientific Director.
Professor Veronesi is the Chairman of the Institute's Scientific Committee, a group that suggests new areas of research for the Institute and monitors the research that is underway. Veronesi is also a member of the Institute's Research Committee, which decides the Institute's research strategy and approves research plans.
"We are extremely pleased that Professor Veronesi and his team will be using CTLM. His group has led many important studies; it is fitting that our revolutionary technology to improve the accuracy of breast cancer detection techniques and to improve case management move forward under their capable direction. We especially thank our local distributor for making this arrangement possible," stated Tim Hansen, Chief Executive Officer, Imaging Diagnostic Systems, Inc. "This marks our fourth sale in Italy and our sixth installation in the country -- a tremendous start for our clinical and commercialization efforts."
Dr. Enrico Cassano, Director of Breast Imaging at the Institute, said, "We are pleased to have this opportunity to work with the CTLM laser breast scanner. It has been used in research and in a clinical capacity at other international sites; now, we will add our expertise to that of the facilities working with this emergent modality. We are confident that our results will confirm the capabilities of CTLM."
The European Institute of Oncology is a comprehensive cancer center, providing diagnostic services and treatment while conducting research and participating in clinical trials. It is one of 30 institutes in Italy declared a Research Institute of Public Interest by the Italian government, a designation which reflects the strong national and international significance of the institutes to which the title is bestowed.
The sale, arranged through an IDSI distributor, was recognized in the fiscal quarter ending September 30, 2005.
The CTLM(R) system is the first patented breast imaging system that utilizes state-of-the-art laser technology and patented algorithms to create 3-D cross-sectional images of the breast. It is a non-invasive, painless examination that does not expose the patient to radiation or require breast compression. Imaging Diagnostic Systems has received CE Marking, CMDCAS (Canada), Canadian License, China SFDA approval, UL listing, ISO 9001:2000- 13488 certification and FDA export certification for its CT Laser Breast Imaging system. The Company is seeking PreMarket Approval (PMA) from the Food and Drug Administration (FDA) for its CTLM(R) system to be used as an adjunct to mammography.
Please visit Imaging Diagnostic Systems' website at: http://www.imds.com for additional information.
In conjunction with the provisions of the Safe Harbor section of the Private Securities Litigation Reform Act of 1995, this news release may contain forward-looking statements pertaining to future anticipated projected plans, performances and developments, as well as other statements relating to future operations. All such forward-looking statements are necessarily only estimates of future results and there can be no assurance that actual results will not materially differ from expectation. Further information on potential factors that could affect Imaging Diagnostic Systems, Inc., is included in the Company's filing with the Securities Exchange Commission.
Investor Relations:
Rick Lutz
404-261-1196
lcgroup@mindspring.com
SOURCE Imaging Diagnostic Systems, Inc.
Rick Lutz for Imaging Diagnostic Systems, Inc., +1-404-261-1196,
lcgroup@mindspring.com
http://www.prnewswire.com
Copyright (C) 2005 PR Newswire. All rights reserved.
Plantation, see posts 4337 and 4334 on this board. They apply just as much today as when they were posted. If you make the effort you can get your answers. I can wait as long as it takes here.
Petrogen Update - EH#3A Well Progress
- Compression Initiative Flows Successful, Natural Gas Rate Increases -
HOUSTON, Oct 20, 2005 /PRNewswire-FirstCall via COMTEX/ -- Petrogen Corp. ( PTGC ) announced today initial natural gas flow rate results from the Company's Emily Hawes Field #3A well (EH#3A) compression initiative. Since the implementation of the initial rate from the first stage of compression installed on the EH#3A, current natural gas production rates from the well have already increased by more than 50% from rates observed prior to Hurricane Rita.
On October 7th, 2005, crews were mobilized to Emily Hawes Field to install the Company's two-stage compression system to help increase and optimize daily natural gas flow rates from the EH#3A. Due to high line pressures on the Northern Natural Gas/Matagorda Offshore Pipeline System sales pipeline (NNG/MOPS), optimum daily natural gas production rates from the EH#3A were being suppressed. The addition of the first stage of compression on the EH#3A will mitigate any further suppression from the NNG/MOPS line pressures.
Currently, natural gas production rates from the EH#3A utilizing initial compression speeds, are averaging between 380 Mcfgd to 500 Mcfgd. As the well continues to clean up, operations personnel indicate compression speeds will be increased within the first stage of compression to further improve gas sales.
Petrogen's Chairman and CEO, Sacha H. Spindler stated, "We are very pleased with the initial flow rate results from the Emily Hawes #3A since the installation of our two-stage compression system. As the well continues to clean up, we have several options that remain available to us that can continue to further improve gas sales from the well. These include increased speeds within the first stage of compression, as well as the implementation of the second stage of available compression that will further improve overall daily natural gas production flow rates."
On November 23, 2004, Petrogen announced that it successfully tested natural gas from the EH#3A well from the Basal Miocene M1 sand with an absolute open flow of 1,998 mcfgd; 978 mcfgd was tested on a 14/64" choke with flowing tubing pressure of 1,395 psi and a final shut-in pressure of 1,950 psi. On May 7, 2005, crews were mobilized to Emily Hawes Field and immediately began an extended production test of the EH#3A well. On August 3rd, 2005 Petrogen announced that it had commenced natural gas sales from the EH#3A well.
The Emily Hawes Field property is located approximately 90 miles southwest of Houston, Texas within the prolific oil and gas producing Miocene-Frio trend of the onshore and offshore Texas Gulf Coast. Near term plans include the expansion of operations through the development of a number of infill and step-out drilling locations to that of the EH#3A well targeted at the Basal Miocene Sands within the Emily Hawes Field.
About Matagorda Island
Matagorda Island is one of seven barrier islands located in the Gulf of Mexico, Texas Gulf Coast. Today, Texas and the Texas Gulf Coast represent one of the premier oil and gas exploration regions in the world, accounting for 32% of all natural gas production and 27% of proved natural gas reserves in the United States. Over the past few years, several large discoveries by Shell, BP and Chevron Texaco have contributed to the growing prominence of the Gulf Coast region as a hotbed for the expansion of domestic natural gas developments. Matagorda Island is approximately 34 miles long by 4 miles wide and is situated along the prolific, natural gas producing Miocene/Frio trend.
About Petrogen
Petrogen Corp. is a Houston, Texas based upstream energy company specializing in the development of natural gas properties in the Texas Gulf Coast region with known hydrocarbon reserves. For further information, please visit the Company's website at http://www.petrogencorp.com.
THIS NEWS RELEASE MAY INCLUDE FORWARD-LOOKING STATEMENTS WITHIN THE MEANING OF SECTION 27A OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, AND SECTION 21E OF THE UNITED STATES SECURITIES AND EXCHANGE ACT OF 1934, AS AMENDED, WITH RESPECT TO ACHIEVING CORPORATE OBJECTIVES, DEVELOPING ADDITIONAL PROJECT INTERESTS, THE COMPANY'S ANALYSIS OF OPPORTUNITIES IN THE ACQUISITION AND DEVELOPMENT OF VARIOUS PROJECT INTERESTS AND CERTAIN OTHER MATTERS. THESE STATEMENTS ARE MADE UNDER THE "SAFE HARBOR" PROVISIONS OF THE UNITED STATES PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 AND INVOLVE RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE IN THE FORWARD-LOOKING STATEMENTS CONTAINED HEREIN.
CONTACTS:
Company Contact
Louis J. Fruchier
V.P. Corporate Development & Communications
Petrogen Corp.
888-875-1155
fruchier@petrogencorp.com
SOURCE Petrogen Corp.
Louis J. Fruchier, V.P. Corporate Development & Communications of Petrogen Corp.,
1-888-875-1155, fruchier@petrogencorp.com
http://www.prnewswire.com
Copyright (C) 2005 PR Newswire. All rights reserved.
FONAR Signs First Upright MRI Group Purchasing Agreement with MAGNET, Inc.
MELVILLE, N.Y.--(BUSINESS WIRE)----FONAR Corporation (NASDAQ:FONR), The MRI Specialist(TM), announced today the signing of its first group purchasing agreement for its Upright(TM) MRI with MAGNET, Inc., one of the largest group purchasing organizations (GPO) in the country with significant coverage of the northeast region and upper midwest. The long term agreement calls for collaborative marketing efforts to MAGNET's member organizations, including 775 acute care hospitals, 5,400 physician practices/clinics, and over 100 free-standing imaging centers.
"We are fortunate to have signed this agreement with FONAR," said Derwood Dunbar, president & CEO of MAGNET Inc. "FONAR's Upright(TM) MRI technology is absolutely cutting edge and no other imaging company has it. There is a definite need for Upright(TM) imaging capabilities by medical care providers. However, many practitioners are unaware that FONAR has commercialized this technology. Together with FONAR, MAGNET's regional groups will co-market the Upright(TM) MRI to our Participating Healthcare Facilities."
Commenting on the MAGNET agreement, Raymond Damadian, president and founder of FONAR, said, "This development is significant for FONAR as well as many patients in need of quality medical care. The endorsement by MAGNET will, for the first time, provide us with unprecedented exposure to an enormous number of health care facilities and medical practitioners. We look forward to teaming with MAGNET, a most respected regional group purchasing organization covering the northeast, Illinois and Ohio, in bringing the benefits of the Upright(TM) MRI to patients served by its members."
"Also important for FONAR is the strategic significance of our Company's first group purchasing organization agreement for the Upright(TM) MRI," continued Dr. Damadian. "As part of our marketing and sales strategy, we intend to pursue other GPO agreements for comprehensive coverage of the United States, while pursuing relationships with distribution partners to further penetrate domestic as well as international markets. We look forward to continued sales growth for FONAR as we progress with our direct sales efforts, create distribution and reseller partnerships, and add GPOs to aid in our marketing initiatives."
As part of the agreement with MAGNET, the GPO's seven regional groups will work with FONAR to identify potential customers for the Upright(TM) MRI and co-market with FONAR on these accounts. The regional groups are Connecticut Hospital Association Shared Services Program of Connecticut, Hospital Central Services Cooperative of Pennsylvania, PRIME, Inc. of Maryland, Southwest Ohio Health Care Affiliates, Association Management Resources of Illinois, Joint Purchasing Corporation/Creative Source Concepts of New York, and Monmouth-Ocean Health Care Cooperative of New Jersey.
About MAGNET:
Founded during the 1979 Middle Atlantic Health Congress, Mid-Atlantic Group Network of Shared Services, Inc. (MAGNET) was created to develop contracts on behalf of its members in the niche market of capital equipment.
MAGNET is one of the oldest, largest, and most experienced shared service organizations in the country. Today, MAGNET serves approximately 12,000 providers, including hospitals, alternate care facilities, and physician practices and clinics with a contract portfolio that includes equipment, services, commodities and the newly emerging area of niche/boutique (innovative and cost-reducing) products. Additional information may be found on the MAGNET Web site at www.magnetgroup.com.
About FONAR:
FONAR was incorporated in 1978, making it the first, oldest and most experienced MRI manufacturer in the industry. FONAR introduced the world's first commercial MRI in 1980, and went public in 1981. Since its inception, the Company has successfully installed MRI scanners for customers around the world. FONAR's stellar product line includes the Upright(TM) MRI (also known as the Stand-Up(TM) MRI), the only whole-body MRI that performs Position(TM) imaging (pMRI(TM)) and scans patients in numerous weight-bearing positions, i.e. standing, sitting, in flexion and extension, as well as the conventional lie-down position. The FONAR Upright(TM) MRI often sees the patient's problem that other scanners cannot because they are lie-down only. With over 100,000 patients scanned, the patient-friendly Upright(TM) MRI has a near zero claustrophobic rejection rate by patients. As a FONAR customer states, "If the patient is claustrophobic in this scanner, they'll be claustrophobic in my parking lot." Approximately 85% of patients are scanned sitting while they watch a 42" flat screen TV. The Company's latest MRI scanner is the FONAR 360(TM), a room-size recumbent scanner that optimizes openness while facilitating physician access to the patient. FONAR is headquartered on Long Island, New York, and has approximately 500 employees. Additional information may be found on the FONAR Web site at www.fonar.com.
MRI Specialist, Stand-Up, Upright, Position, PMRI and The Proof is in the Picture are trademarks of FONAR.
This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company's financial results may be found in the company filings with the Securities and Exchange Commission.
FONAR Daniel Culver, 631-694-2929 www.fonar.com or Investor Relations Contact: Darrow Associates, Inc. Jordan M. Darrow, 631-367-1866 jdarrow@optonline.net
10/20/2005 06:00 ET
Here is information on IMDS ...
Imaging Diagnostic Systems Inc.
6531 NW 18th Court
Plantation, FL 33313
Phone: 954-581-9800
Fax: 954-581-0555
Web Site: http://www.imds.com
BUSINESS SUMMARY
Imaging Diagnostic Systems, Inc., a development stage company, engages in the research, development, and marketing of a noninvasive breast imaging system. The company has developed Computed Tomography Laser Breast Imaging system that utilizes laser technology and proprietary algorithms to create three dimensional cross sectional images of the breast without the use of x-rays and compression. It sells its products to hospitals in China and the United Arab Emirates. Imaging Diagnostic Systems is headquartered in Plantation, Florida.
Financial Information:
http://finance.yahoo.com/q/pr?s=IMDS.OB
otcstockexchange.com: Stock Watch Alert -- OTCStockExchange.com PTGC, LLLI, FPLF, PYST
Rochester, NY, Oct 19, 2005 (M2 PRESSWIRE via COMTEX) -- OTCStockExchange.com's "Stock Watch Alert" this morning are Petrogen Corp. (OTCBB: PTGC), Lamperd Less Lethal Inc. (OTCBB: LLLI), First Pet Life, Inc. (Pink Sheets: FPLF), Paystar Corporation (Pink Sheets: PYST).
Sign-up for our FREE Stock Alerts at http://www.otcstockexchange.com !
Petrogen Corp. (OTCBB: PTGC - http://finance.yahoo.com/q?s=PTGC.OB )
Petrogen Corp., announced that it has commenced location preparations to drill its first well, the Tiller Ranch #1, on the Company's newly-acquired Texas Gulf Coast property, the Tiller Ranch Lease (the "Lease"). The Lease is located within Tom Graham Field, Jim Wells County, Texas, which has produced over thirteen billion cubic feet of natural gas (13 Bcfg) from twenty-five distinct sands as well as six million eight hundred thousand barrels of oil (6.8 Mmbo) from six sands. The Tiller Ranch #1 will be drilled to test the multiple Frio and Vicksburg age reservoir sands. Extensive subsurface control, provided by approximately twenty-five wells located on or adjacent to the Lease, indicate that potentially up to 18 Bcfe of natural gas reserves could be recovered through the development of up to six new wells.
Petrogen's Chairman and CEO, Sacha H. Spindler stated, "Petrogen's operational focus is to attempt to fully develop Tiller Ranch over the course of the coming two fiscal quarters. With as many as six possible new well drilling locations to spud at Tiller Ranch, we have the potential to increase the Company's reserve base and oncoming revenue stream significantly."
The Lease consists of potential natural gas exploitation opportunities trapped along a north-south striking, underdeveloped, low relief anticline. The majority of wells on the Lease were drilled during the 1940's and 1950's when local natural gas prices were in the $0.02 -- $0.10 per Mcf range. These extremely low gas prices resulted in limited development of the natural gas reserves on the Lease, providing for substantial infill and step out drilling potential. Wells in the area have average production histories of approximately eight to ten years with cumulative production of approximately 3.0 Bcfg per well. Extensive natural gas infrastructure exists within the area providing for immediate transportation and sales of any potential upcoming natural gas production.
Current gas prices for potential production from the Tiller Ranch area are approximately in the $11.00 -- $11.50 per Mcf range and will be sold into the Enterprise Products Partners gas pipeline system in South Texas.
Mr. Spindler further stated, "Tiller Ranch is another example of the high caliber opportunities Petrogen strives to develop in the Texas Gulf Coast. It possesses significant geologic data and well control along proven hydrocarbon- producing trends that enables the Company to greatly reduce its geologic risk while increasing its degree of confidence that the 18 billion cubic feet of indicated potential reserves can be readily exploited through our current drilling initiative."
Lamperd Less Lethal Inc. (OTCBB: LLLI - http://finance.yahoo.com/q?s=LLLI.OB )
Mr. Barry Lamperd, President and CEO is pleased to announce that Lamperd entered into an exclusive distributor agreement dated September 30, 2005 with Laser Shot, Inc., pursuant to which Lamperd was appointed the agent of Laser Shot, Inc. to promote and solicit orders of all products listed and described in Laser Shot's official catalogue, and to provide after-purchase support, on an exclusive basis in Canada. The Laser Shot Dynamic Simulator System is utilized for law enforcement and military training.
In order to maintain these exclusive distribution rights in Canada, Lamperd must purchase and pre-pay at least $50,000.00 worth of Laser Shot's product per calendar quarter, adjusted annually. In addition, Lamperd may manufacture the Mobile Modular Shooting Range for Laser Shot. The modular range is used by police departments that have a need for a live fire training range but do not have the ability to upgrade their existing range or construct a new range. Lamperd must pay Laser Shot a licensing fee of 15% of the retail price of any modular range that Lamperd might elect to build. The agreement has an initial term of three years, and thereafter until terminated by either party on ninety days notice.
In addition, Lamperd confirms that it has received approval for the importation of its Defender launcher into the United States for sale. The Bureau of Alcohol, Tobacco and Firearms provided such approval, under license number 903050/ELG.
First Pet Life, Inc. (Pink Sheets: FPLF - http://finance.yahoo.com/q?s=FPLF.PK )
First Pet Life, Inc. announced that Market Advisors, Inc. has initiated coverage on their company with an intermediate-term price objective of $7 per share. This very aggressive price objective is contingent on the company securing a contract with a major insurance underwriter, which is in negotiation at the present time.
Paystar Corporation (Pink Sheets: PYST - http://finance.yahoo.com/q?s=PYST.PK )
Paystar Corporation focuses on four business areas: cashless teller machine (CTM) services, which is managed by its wholly owned subsidiary, U.S. Cash Exchange, Inc.; wholesale carrier services, switching platforms, and software support, which is managed by other wholly owned subsidiary, SHS Communications, Inc.; Internet ATM and prepaid debit card services, managed by other wholly owned subsidiary, GLOBALCash, Inc.; and Internet kiosk services, which is managed by its other wholly owned subsidiary, PayStar InfoStations, Inc. The company currently manages approximately 607 CTM units and holds in inventory another 427 units. These units provide individuals the mechanism to use their bank debit card to obtain on-the-spot scrip to purchase items and to obtain cash for use in various retail stores using funds from their bank savings or checking accounts for a fee. Generally, the scrip machines are located in convenience and liquor stores, fast food and other restaurants, gas stations, video and entertainment facilities, and other high traffic merchant locations throughout the United States. Paystar currently has Internet kiosks installed and operating in several major cities and locations throughout the country, including airports in Seattle, Portland, Cincinnati, and Denver. The company markets its services through trade shows and trade magazines to the prepaid market, cellular, public, and private telephone companies.
About OTCStockExchange.com
OTCStockExchange.com (OTCS) is a leading investor relations firm whose primary focus is promoting awareness among brokers, investors, and others in the investment community who are interested in small and micro-cap companies. OTCS is dedicated to helping publicly traded companies gain the exposure they need to move forward with the development of their business plans. OTCS's goal is to feature equity investments in micro or small capitalization companies that have the potential for long-term appreciation. OTCS provides all investors with the latest news, press releases, investment opinions, and research reports for all the companies highlighted on the site. OTCS offers a free financial newsletter. To subscribe or get more information, visit our home page located at http://www.otcstockexchange.com .
We offer many investor relations programs to public companies. To feature a company on our web site or in our daily Newsletter or Mid-Day Stock Alert, please contact Chris Wheeler at 585-330-8514 , or via email at info@otcstockexchange.com .
OTCStockExchange.com (OTCS) based upon information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by OTCS to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. OTCS is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.otcstockexchange.com or mentioned herein. OTCS has been compensated by third party shareholders or with cash from the company on behalf of one or more of the companies mentioned in this opinion.
OTCS's affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event of a rise in value. OTCS will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and OTCS undertakes no obligation to update such statements.
CONTACT: Chris Wheeler Tel: +1 585 330 8514 e-mail: info@otcstockexchange.com WWW: http://www.otcstockexchange.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
otcstockexchange.com: Stock Watch Alert -- OTCStockExchange.com PTGC, LLLI, FPLF, PYST
Rochester, NY, Oct 19, 2005 (M2 PRESSWIRE via COMTEX) -- OTCStockExchange.com's "Stock Watch Alert" this morning are Petrogen Corp. (OTCBB: PTGC), Lamperd Less Lethal Inc. (OTCBB: LLLI), First Pet Life, Inc. (Pink Sheets: FPLF), Paystar Corporation (Pink Sheets: PYST).
Sign-up for our FREE Stock Alerts at http://www.otcstockexchange.com !
Petrogen Corp. (OTCBB: PTGC - http://finance.yahoo.com/q?s=PTGC.OB )
Petrogen Corp., announced that it has commenced location preparations to drill its first well, the Tiller Ranch #1, on the Company's newly-acquired Texas Gulf Coast property, the Tiller Ranch Lease (the "Lease"). The Lease is located within Tom Graham Field, Jim Wells County, Texas, which has produced over thirteen billion cubic feet of natural gas (13 Bcfg) from twenty-five distinct sands as well as six million eight hundred thousand barrels of oil (6.8 Mmbo) from six sands. The Tiller Ranch #1 will be drilled to test the multiple Frio and Vicksburg age reservoir sands. Extensive subsurface control, provided by approximately twenty-five wells located on or adjacent to the Lease, indicate that potentially up to 18 Bcfe of natural gas reserves could be recovered through the development of up to six new wells.
Petrogen's Chairman and CEO, Sacha H. Spindler stated, "Petrogen's operational focus is to attempt to fully develop Tiller Ranch over the course of the coming two fiscal quarters. With as many as six possible new well drilling locations to spud at Tiller Ranch, we have the potential to increase the Company's reserve base and oncoming revenue stream significantly."
The Lease consists of potential natural gas exploitation opportunities trapped along a north-south striking, underdeveloped, low relief anticline. The majority of wells on the Lease were drilled during the 1940's and 1950's when local natural gas prices were in the $0.02 -- $0.10 per Mcf range. These extremely low gas prices resulted in limited development of the natural gas reserves on the Lease, providing for substantial infill and step out drilling potential. Wells in the area have average production histories of approximately eight to ten years with cumulative production of approximately 3.0 Bcfg per well. Extensive natural gas infrastructure exists within the area providing for immediate transportation and sales of any potential upcoming natural gas production.
Current gas prices for potential production from the Tiller Ranch area are approximately in the $11.00 -- $11.50 per Mcf range and will be sold into the Enterprise Products Partners gas pipeline system in South Texas.
Mr. Spindler further stated, "Tiller Ranch is another example of the high caliber opportunities Petrogen strives to develop in the Texas Gulf Coast. It possesses significant geologic data and well control along proven hydrocarbon- producing trends that enables the Company to greatly reduce its geologic risk while increasing its degree of confidence that the 18 billion cubic feet of indicated potential reserves can be readily exploited through our current drilling initiative."
Lamperd Less Lethal Inc. (OTCBB: LLLI - http://finance.yahoo.com/q?s=LLLI.OB )
Mr. Barry Lamperd, President and CEO is pleased to announce that Lamperd entered into an exclusive distributor agreement dated September 30, 2005 with Laser Shot, Inc., pursuant to which Lamperd was appointed the agent of Laser Shot, Inc. to promote and solicit orders of all products listed and described in Laser Shot's official catalogue, and to provide after-purchase support, on an exclusive basis in Canada. The Laser Shot Dynamic Simulator System is utilized for law enforcement and military training.
In order to maintain these exclusive distribution rights in Canada, Lamperd must purchase and pre-pay at least $50,000.00 worth of Laser Shot's product per calendar quarter, adjusted annually. In addition, Lamperd may manufacture the Mobile Modular Shooting Range for Laser Shot. The modular range is used by police departments that have a need for a live fire training range but do not have the ability to upgrade their existing range or construct a new range. Lamperd must pay Laser Shot a licensing fee of 15% of the retail price of any modular range that Lamperd might elect to build. The agreement has an initial term of three years, and thereafter until terminated by either party on ninety days notice.
In addition, Lamperd confirms that it has received approval for the importation of its Defender launcher into the United States for sale. The Bureau of Alcohol, Tobacco and Firearms provided such approval, under license number 903050/ELG.
First Pet Life, Inc. (Pink Sheets: FPLF - http://finance.yahoo.com/q?s=FPLF.PK )
First Pet Life, Inc. announced that Market Advisors, Inc. has initiated coverage on their company with an intermediate-term price objective of $7 per share. This very aggressive price objective is contingent on the company securing a contract with a major insurance underwriter, which is in negotiation at the present time.
Paystar Corporation (Pink Sheets: PYST - http://finance.yahoo.com/q?s=PYST.PK )
Paystar Corporation focuses on four business areas: cashless teller machine (CTM) services, which is managed by its wholly owned subsidiary, U.S. Cash Exchange, Inc.; wholesale carrier services, switching platforms, and software support, which is managed by other wholly owned subsidiary, SHS Communications, Inc.; Internet ATM and prepaid debit card services, managed by other wholly owned subsidiary, GLOBALCash, Inc.; and Internet kiosk services, which is managed by its other wholly owned subsidiary, PayStar InfoStations, Inc. The company currently manages approximately 607 CTM units and holds in inventory another 427 units. These units provide individuals the mechanism to use their bank debit card to obtain on-the-spot scrip to purchase items and to obtain cash for use in various retail stores using funds from their bank savings or checking accounts for a fee. Generally, the scrip machines are located in convenience and liquor stores, fast food and other restaurants, gas stations, video and entertainment facilities, and other high traffic merchant locations throughout the United States. Paystar currently has Internet kiosks installed and operating in several major cities and locations throughout the country, including airports in Seattle, Portland, Cincinnati, and Denver. The company markets its services through trade shows and trade magazines to the prepaid market, cellular, public, and private telephone companies.
About OTCStockExchange.com
OTCStockExchange.com (OTCS) is a leading investor relations firm whose primary focus is promoting awareness among brokers, investors, and others in the investment community who are interested in small and micro-cap companies. OTCS is dedicated to helping publicly traded companies gain the exposure they need to move forward with the development of their business plans. OTCS's goal is to feature equity investments in micro or small capitalization companies that have the potential for long-term appreciation. OTCS provides all investors with the latest news, press releases, investment opinions, and research reports for all the companies highlighted on the site. OTCS offers a free financial newsletter. To subscribe or get more information, visit our home page located at http://www.otcstockexchange.com .
We offer many investor relations programs to public companies. To feature a company on our web site or in our daily Newsletter or Mid-Day Stock Alert, please contact Chris Wheeler at 585-330-8514 , or via email at info@otcstockexchange.com .
OTCStockExchange.com (OTCS) based upon information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by OTCS to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. OTCS is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.otcstockexchange.com or mentioned herein. OTCS has been compensated by third party shareholders or with cash from the company on behalf of one or more of the companies mentioned in this opinion.
OTCS's affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event of a rise in value. OTCS will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and OTCS undertakes no obligation to update such statements.
CONTACT: Chris Wheeler Tel: +1 585 330 8514 e-mail: info@otcstockexchange.com WWW: http://www.otcstockexchange.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
(C)1994-2005 M2 COMMUNICATIONS LTD
-0-
OTCPicks.com: Daily Market Movers Digest Stock Alerts, Tuesday, October 18th, VMHVF, GFPE, LLLI, NWPO, WTVN, UPDA
Oct 18, 2005 (M2 PRESSWIRE via COMTEX) -- Today our stock watch alerts today include Featured Profile for VideoMovieHouse.com (OTCBB: VMHVF), Gulf Petroleum Exchange, Inc. (OTC: GFPE) and stock alerts for Lamperd Less Lethal, Inc. (OTCBB: LLLI), Newport International Group (OTCBB:NWPO), Wi-Fi TV, Inc. (OTC: WTVN), Universal Property Development and Acquisition Corporation (OTCBB: UPDA).
FEATURED STOCK PROFILE
VIDEOMOVIEHOUSE.COM INC. (OTCBB: VMHVF)
Detailed Quote: http://www.otcpicks.com/quotes/VMHVF.php
View Company Profile: http://www.otcpicks.com/profiles/vmhvf/index.php
Videomoviehouse.com, Inc. (OTCBB: VMHVF) is a rising star in the VHS and DVD movie Internet sales and online subscription rental markets. The company sells and rents video DVD's through it web site www.videomoviehouse.com, and also is one of the largest video retailers on Amazon.com, Ebay.com, and Half.com.
INVESTOR HIGHLIGHTS:
1. Largest 3rd party DVD seller on Amazon.com, Ebay and Half.com
2. More than 60,000 DVD titles in their catalog and still growing.
3. Recently announced its entrance into the 8 Billion dollar DVD rental market offering online DVD rental services similar to NetFlix and Blockbuster Video.
4. Announced an Affiliate Program in July targeted at fund raising organizations. The company is busy signing up new affiliates who are in turn signing up new VMH online DVD rental subscribers. As their affiliate program grows, so will their online DVD video rental business.
5. One of the largest Canadian DVD resellers and has goal to be #1 in Canada in online DVD rentals very soon, a market where NetFlix and Blockbuster do not play.
6. A significant portion of their DVD sales revenue is for international sales. They sell a lot of DVD in the UK, and have recently announced a new web site VideoMovieHouse.in which is targeted at DVD sales in India. The Indian market is largely english speaking and has very few options to purchase US movies. VideoMovieHouse.in sells US movies which it ships to Indian customers and they can make their purchases using the Rupee currency.
7. VideoMovieHouse.com recently signed an MOU to acquire DVD Marketplace.com, an established online DVD retailer. This acquisition provide both a web business as well as a flexible software e-commerce platform for the creation of other online retail sites with strong support for 3rd party merchants. This is a software platform that can allow the company to open many different web sites targeting various vertical markets, countries, languages and currencies. It is much like Amazon's software platform in that it is built to allow third party vendors to sell all types of products through the platform. Web sites that could be built from this could include sites that feature everything from electronics, to books, to appliances, to entertainment offerings, and more.
VMHVF News:
October 17 - VideoMovieHouse.com Announces Record Annual Sales of $3,600,000 for Fiscal Year 2005 -- a Year Over Year Increase of 153%
Steve Gaspar, President of VMH VideoMovieHouse.com Inc. (OTC BB: VMHVF), is pleased to announce that VideoMovieHouse.com experienced a year over year increase of 153% in sales growth during 2005. According to Mr. Gaspar, virtually all of the growth in 2005 was due to an increase in domestic sales. "In the upcoming year I not only see similar growth on the domestic sales front but our other endeavours should begin bearing fruit as well. Revenues from monthly DVD rental subsciption fees, sales of DVDs and other video products into the Indian marketplace, plus fees which we expect to collect from merchants selling on our soon-to-be-launched 3rd-party Marketplace sales platforms, should add dramatically to next year's total overall revenue," added Mr. Gaspar.
VideoMovieHouse.com recently entered the online DVD rental market in North America, an area that has seen significant success by NFLX and BBI. The company plans to launch new websites allowing other sellers to market their products worldwide in a similar fashion to the Amazon.com, Half.com and Rediff.com marketplace formats. The company also recently signed a worldwide disribution agreement with Columbia Films to market that company's line of Tamil Indian Films worldwide. In addition, the company announced on Sept. 15, 2005, its plans to acquire www.dvdmarketplace.com, an established online DVD retailer offering entertainment products for sale from third-party merchants in the USA.
FEATURED STOCK PROFILE
GULF PETROLEUM EXCHANGE, INC. (OTC: GFPE) "Up 66.66% on Monday"
Detailed Quote: http://www.otcpicks.com/quotes/GFPE.php
View Company Profile: http://www.otcpicks.com/profiles/gfpe/index.php
The founder and current president of Gulf Petroleum, Warren (Skip) Wheeler, has over 45 years' experience in drilling, production, refining and upstream sales sectors of the oil industry, and organized Gulf Petroleum Exchange in 1997 as a fuel and crude oil trading and brokering company. However, due to the precipitous decline in oil prices in late 1997, the company began utilizing the acquired knowledge of its president to perform on-site demulsification and reclamation of non-hazardous industrial and oilfield waste hydrocarbons and selling the resultant products into the appropriate markets, i.e. industrial fuel oil, crude oil etc.
Gulf Petroleum's goal is clear and straightforward, which is: determination to build a profitable company with a high revenue dollar per employee per barrel sold. To accomplish this requires engaging top-of-the-line people and outsourcing as much of the mundane as possible. Our motto is "Do a lot with a little"
Recent Announcements:
1. Gulf Petroleum Exchange, Inc. and Jeanblanc International Inc., a developer of a proprietary hydrocarbon desulfurization process, have entered into an agreement in which Gulf Petroleum will design the internal equipment of the desulfurizing plant for the separation of sulfur compounds from the hydrocarbons. Gulf Petroleum and Jeanblanc signed a 5-year evergreen contract. The contract is for the internal design, construction and management of the desulfurization plants for Petroleos Mexicanos (Mexican National Oil Company - PEMEX).
2. Gulf Petroleum Exchange, Inc. announced they have entered a Joint Venture agreement to Drill 5 Oil Wells at a time with Smith Oil Co. Smith Oil Co. is a 40-year-old oil production company, producing on 3,000 Contiguous Acres in the Illinois Basin (Western Kentucky Region). The Illinois Basin extends from central western Indiana through southern Illinois into western Kentucky and is historically a prolific oil and gas producing area; it has several oil-bearing formations that produce crude oil and gas as shallow as 250 feet. Recent calculations indicate that remaining recoverable resources in the Illinois Basin may be as much as 4.1 billion barrels. Thus, large quantities of oil, potentially recoverable using current technology, remain in the Illinois Basin oil fields.
OTC STOCK ALERTS
LAMPERD LESS LETHAL, INC. (OTCBB: LLLI) "Up 17.14% on Monday"
Detailed Quote: http://www.otcpicks.com/quotes/LLLI.php
Founded in 1994, Lamperd Less Lethal is a multi-national supplier of less-lethal weapons and safety equipment to police, government, and military agencies. It currently manufactures more than 250 different products ranging from body protective gear to blunt impact weapons systems. These weapon systems are being positioned in the market as the newest generation of less-lethal weapons suitable for use in a wide range of challenging circumstances, including urban warfare, counter-terrorism, law enforcement, and public security. Lamperd Less Lethal is a certified supplier of law enforcement products for the USA, Canada, and NATO.
NEWPORT INTERNATIONAL GROUP, INC. (OTCBB: NWPO) "Up 13.01% on Monday"
Detailed Quote: http://www.otcpicks.com/quotes/NWPO.php
Newport International Group (OTCBB:NWPO) is dedicated to leveling the digital playing field for small- and medium-sized companies. Its two subsidiaries provide digital tools and services that are as powerful as those available to large enterprises, but are designed and developed so that technical skills aren't needed to use or manage them. The company has headquarters in Palm Desert, with technology development in Phoenix. More information is available at www.nwpo.biz.
NWPO News:
October 17 - Newport International Group Hires Former Dell Product and Business Development Manager as COO of Its Spare Backup Subsidiary
Newport International Group (OTCBB: NWPO) announced today the hiring of Greg Rusu as Chief Operating Officer of its Spare Backup Inc. subsidiary. Mr. Rusu was most recently Manager of Product/Business Development at Dell, where for the past 5 years his responsibilities included creating product roadmaps, deploying support services and creating departmental efficiencies to reduce operating costs. While at Dell, he created revenue producing opportunities within support and was responsible for generating significant annualized revenue from proof of concept testing. Prior to his employment at Dell, Mr. Rusu spent 10 years at Advanced Micro Devices where he managed corporate alliances with companies including Oracle, Computer Associates, Hewlett Packard and Red Hat. While at AMD, he focused on building market share for several of the AMD Athlon family of products and also led strategy, preparation and logistics for inter-company executive alignment and PR communications.
Commenting on this hiring, Cery Perle, CEO of Newport International Group, Inc. stated, "We are extremely pleased to add Greg to our senior management team at Spare. His operational expertise in product deployment, coupled with his extensive experience in OEM relationship building will be a key factor in helping Spare build its product line. Greg's understanding of cost effective brand building and customer support structuring will no doubt prove to be invaluable to the Spare team of professionals."
On his joining the company, Greg Rusu stated, "Throughout my career in product development, there have been numerous opportunities for me to leave the corporate giants and take the reigns of a small technology rich company and I have chosen to pass on every opportunity until Spare. The product line, the people and the opportunity were just too much to pass up and I am looking forward to making Spare the default solution for backup and data migration needs."
The Spare Backup Solution
Spare is a fully automated remote backup solution. It starts by scanning a user's hard drive, including the desktop and e-mail programs, for files and the application components necessary to produce an exact replica of the original. Then it transports the data, including new and revised files, daily to twin data centers on both U.S. coasts. Files are triple-encrypted and users can access them from any broadband, Web-connected computer anywhere. For more information and a free fourteen day trial visit http://www.sparebackup.com.
About Spare Backup Inc.
Spare Backup Inc., a subsidiary of Newport International Group, is the developer of Spare Backup service, the first online backup service specifically designed for small business and home business users.
WI-FI TV, INC. (OTC: WTVN) "Up 20% on Monday"
Detailed Quote: http://www.otcpicks.com/quotes/WTVN.php
Wi-Fi TV, Inc. offers free local, long distance, and global telephone service with its Wi-Fi TV virtual dialer and 200 free one-click Wi-Fi TV content channels at www.Wi-FiTV.com. Wi-Fi TV, Inc. (www.wi-fitv.com) (www.cinemapop.com) has a history of innovation in online content delivery and plans to quantify the value of this unique experience now that high-speed Internet delivery is becoming available to millions of consumers around the world. Wi-Fi TV draws on the latest IPTV technology and 10 years of experience in the delivery of video over the Internet in launching its new service.
UNIVERSAL PROPERTY DEVELOPMENT & ACQUISITION CORP (OTCBB: UPDA) "Up 25.38% on Monday"
Detailed Quote: http://www.otcpicks.com/quotes/UPDA.php
Universal Property Development and Acquisition Corporation (OTCBB: UPDA) focuses on the acquisition and development of proven oil and natural gas reserves and other energy opportunities through the creation of joint ventures with under-funded owners of mineral leases and cutting-edge technologies.
UPDA News:
October 17 - UPDA Reports to Its Shareholders
In order to better communicate with its shareholders and interested investors, the board and management of UPDA (OTCBB:UPDA) will periodically report on the progress and state of the company. The following is the first of those reports.
On the operational side: UPDA completed its restructuring on July 11, 2005. Since then, it has entered into two oil and gas joint ventures. The first of these ventures is Canyon Creek Oil and Gas, Inc. (CCOG), in the state of Texas, and the second is West Oil and Gas, Inc. (West), in Utah.
CCOG is a joint venture with USProduction and Exploration, LLC (USPX). UPDA initially provided funding for the work-over of oil and gas wells on three properties and 2000 acres. Since then, UPDA funded the acquisition of four additional oil and gas properties, which increased the reserves of CCOG from $35 million to close to $200 million according to in-house estimates. The CCOG Coleman field is in partial production in both oil and gas since the last week of September and the work-over is being carried out on most of the other fields. As a result of UPDA's increased investment, its stake in CCOG will be increased to sixty five percent (65%).
West, a joint venture with Dark Horse Exploration and the Masaood Group USA, was signed in early October and consists of 4000 acres with six existing wells. As previously reported, this property contains reserves conservatively valued at approximately $500 million according to a proven reserve study. Work-over on one well has been completed and is in progress on the others. The Masaood Group USA will provide the necessary funding for the remaining work-over and the additional drilling of eighty (80) wells. UPDA controls sixty percent (60%) of West.
On Fiscal issues: The Board has been able to reduce the debt that was carried on the UPDA books by converting most of it to restricted equities. In addition, through an amended investment agreement, the chairman had provided UPDA with preferred securities valued at one million dollars and reduced the amount of outstanding common stock by over 1.4 million shares. This transaction was reported on the last 8-K that was filed October 10, 2005. These actions have improved the UPDA balance sheet and created shareholders' equity.
On Human Resources matters: In an effort to build a competent team to better serve the interests of the shareholders, the UPDA board is considering the engagement of two oil and gas specialists. The first is a field professional that will be retained to periodically inspect the expanding inventory of wells and report to the management on production issues. The second is a certified oil and gas geologist who will assist the board on future acquisitions. An office manager is also being interviewed in order to account for the revenues that will soon be reported.
On Real Estate projects: The UPDA board voted to disengage from all real estate transactions and to assign or transfer any transaction that had been in progress. This includes the Brathanhl building in Cleveland, the 600 Acres in Reno, the 42 acres in Florida and the Tucker project in Atlanta. As a result of these actions, UPDA will be able to focus its efforts and capital on the many oil and gas opportunities under consideration.
The Board of Directors of UPDA is committed to building and growing this company in the energy sector. As demonstrated by the progress of the past three months, UPDA is attaining its goals through the formation of Joint Ventures with energy partners and by expanding its existing joint ventures. UPDA will continue to strive to create and enhance its shareholders' value.
ABOUT OTCPICKS.COM
OTCPicks.com is an Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Profile Research Reports authored by our financial writers. We publish a daily Newsletter to subscibers, and we publish our Daily Market Movers Digest which is sent out on the M2 Presswire several times daily highlighting hot OTC and OTCBB stocks. To feature a company on our web site or in our daily Newsletter or Market Mover's Digest, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our web site, or joining our opt-in email list.
Release of Liability: Through use of this website viewing or using you agree to hold OTCPicks.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a representation by the publisher nor a solicitation of the purchase or sale of any securities. OTCPicks.com has been compensated seventy thousand rule 144 shares by the company for VMHVF advertising and promotional services, and the publisher has purchased free trading shares on the open market and still holds all shares. OTCPicks.com has been compensated fifty thousand free trading shares by a third party for GFPE advertising and promotional services. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. We encourage readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and we make no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. OTCPicks.com and its affiliates are not registered investment advisors or a broker dealers. Readers should note that investments in companies profiled are considered to be high risk and use of the information provided is at the investor's sole risk. OTCPicks.com also advises that the purchase of such high risk securities may result in the loss of some or all of the investment. Investors should not rely solely on the information presented. Rather, investors should use the information provided by the profiled companies as a starting point for doing additional independent research on the profiled companies in order to allow the investor to form his or her own opinion regarding investing in the profiled companies. Factual statements made by the profiled companies are made as of the date stated and are subject to change without notice. Investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. OTCPicks.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through our web site, news letter, or press releases. OTCPicks.com owners may or may not hold positions in the companies that are profiled.
The information contained herein contains forward-looking information within the meaning of Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of the company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect the company's actual results of operation. Factors that could cause actual results to differ include the size and growth of the market for the company's products, the company's ability to fund its capital requirements in the near term and in the long term, pricing pressures, unforeseen and/or unexpected circumstances in happenings, pricing pressures, etc. Investing in securities is speculative and carries risk. Past performance does not guarantee future results.
Third Party Web Sites and Information: Our web site and newsletter may provide hyperlinks to third party websites or access to third party content. We do not control, endorse, or guarantee content found in such sites. You agree that OTCPicks.com is not responsible for any content, associated links, resources, or services associated with a third party site. You further agree that our company shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.
CONTACT: Brian Dean, Publisher, OTCPicks.com Tel: +1 972 546 3740 e-mail: publisher@otcpicks.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
(C)1994-2005 M2 COMMUNICATIONS LTD
-0-
Imaging Diagnostic Systems to Participate in Venezuelan Congress
Lectures Introduce CT Laser Mammography to the Region
FORT LAUDERDALE, Fla., Oct 18, 2005 /PRNewswire-FirstCall via COMTEX/ -- Imaging Diagnostic Systems, Inc., ( IMDS ) announced today that Jose Cisneros, M.D., Ph.D., IDSI Associate Director of Clinical Research, will present two lectures at the Tenth Venezuelan Congress of Radiology and Diagnostic Imaging from Oct. 19 through Oct. 22 at the Hotel InterContinental, Maracaibo, Venezuela.
As part of a symposium on women's health, Dr. Cisneros will discuss the scientific and clinical fundamentals of the CTLM system as well as the role of angiogenesis in the early detection of cancer.
The lectures will introduce the concept of CT Laser Mammography to the region through IDSI's market development initiative in South America. CTLM was launched in Central and South America with a sale in Argentina and two lectures at the Argentinean Congress of Radiology and Diagnostic Imaging. Based on the scientific and commercial interest generated, IDSI will continue to form partnerships, gain sites, and contribute to congresses and symposia in South America.
"The opportunities that we have had in South America have enabled us to introduce the CTLM system to two separate regions, reaching many influential medical centers and prominent physicians. We are very pleased with the exposure we have gained and look forward to the success of the development initiative," stated Deborah O'Brien, IDSI Senior Vice President.
The Venezuelan Congress is an annual radiology meeting that attracts physicians from Colombia, Venezuela, the Caribbean, and Central America. This year's meeting is a joint event with the Radiological Society of Panama.
The CTLM(R) system is the first patented breast imaging system that utilizes state-of-the-art laser technology and patented algorithms to create 3-D cross-sectional images of the breast. It is a non-invasive, painless examination that does not expose the patient to radiation or require breast compression. Imaging Diagnostic Systems has received CE Marking, CMDCAS (Canada), Canadian License, China SFDA approval, UL listing, ISO 9001:2000- 13488 certification and FDA export certification for its CT Laser Breast Imaging system. The Company is seeking PreMarket Approval (PMA) from the Food and Drug Administration (FDA) for its CTLM(R) system to be used as an adjunct to mammography.
Please visit Imaging Diagnostic Systems' website at: http://www.imds.com for additional information.
In conjunction with the provisions of the Safe Harbor section of the Private Securities Litigation Reform Act of 1995, this news release may contain forward-looking statements pertaining to future anticipated projected plans, performances and developments, as well as other statements relating to future operations. All such forward-looking statements are necessarily only estimates of future results and there can be no assurance that actual results will not materially differ from expectation. Further information on potential factors that could affect Imaging Diagnostic Systems, Inc., is included in the Company's filing with the Securities Exchange Commission.
Investor Relations:
Rick Lutz
404-261-1196
lcgroup@mindspring.com
SOURCE Imaging Diagnostic Systems, Inc.
Investor Relations, Rick Lutz, +1-404-261-1196, or lcgroup@mindspring.com, for
Imaging Diagnostic Systems
http://www.prnewswire.com
Copyright (C) 2005 PR Newswire. All rights reserved.
Petrogen Prepares New Well Drilling Location at Tiller Ranch
- Texas Gulf Coast Natural Gas Development Project Underway -
HOUSTON, Oct 18, 2005 /PRNewswire-FirstCall via COMTEX/ -- Petrogen Corp. (OTC Bulletin Board: PTGC), announced today that it has commenced location preparations to drill its first well, the Tiller Ranch #1, on the Company's newly-acquired Texas Gulf Coast property, the Tiller Ranch Lease (the "Lease"). The Lease is located within Tom Graham Field, Jim Wells County, Texas, which has produced over thirteen billion cubic feet of natural gas (13 Bcfg) from twenty-five distinct sands as well as six million eight hundred thousand barrels of oil (6.8 Mmbo) from six sands. The Tiller Ranch #1 will be drilled to test the multiple Frio and Vicksburg age reservoir sands. Extensive subsurface control, provided by approximately twenty-five wells located on or adjacent to the Lease, indicate that potentially up to 18 Bcfe of natural gas reserves could be recovered through the development of up to six new wells.
Petrogen's Chairman and CEO, Sacha H. Spindler stated, "Petrogen's operational focus is to attempt to fully develop Tiller Ranch over the course of the coming two fiscal quarters. With as many as six possible new well drilling locations to spud at Tiller Ranch, we have the potential to increase the Company's reserve base and oncoming revenue stream significantly."
The Lease consists of potential natural gas exploitation opportunities trapped along a north-south striking, underdeveloped, low relief anticline. The majority of wells on the Lease were drilled during the 1940's and 1950's when local natural gas prices were in the $0.02 -- $0.10 per Mcf range. These extremely low gas prices resulted in limited development of the natural gas reserves on the Lease, providing for substantial infill and step out drilling potential. Wells in the area have average production histories of approximately eight to ten years with cumulative production of approximately 3.0 Bcfg per well. Extensive natural gas infrastructure exists within the area providing for immediate transportation and sales of any potential upcoming natural gas production. Current gas prices for potential production from the Tiller Ranch area are approximately in the $11.00 -- $11.50 per Mcf range and will be sold into the Enterprise Products Partners gas pipeline system in South Texas.
Mr. Spindler further stated, "Tiller Ranch is another example of the high caliber opportunities Petrogen strives to develop in the Texas Gulf Coast. It possesses significant geologic data and well control along proven hydrocarbon- producing trends that enables the Company to greatly reduce its geologic risk while increasing its degree of confidence that the 18 billion cubic feet of indicated potential reserves can be readily exploited through our current drilling initiative."
About The Texas Gulf Coast
Texas and the Texas Gulf Coast represent one of the premier natural gas exploration and development regions in the world, accounting for 32% of all natural gas production and 27% of proved natural gas reserves in the United States. Over the past few years, several large discoveries by Shell, BP and Chevron Texaco have contributed to the growing prominence of the Gulf Coast region as a hotbed for the expansion of domestic natural gas developments.
About Petrogen
Petrogen Corp. is a Houston, Texas based upstream energy company specializing in the development of natural gas properties in the Texas Gulf Coast region with known hydrocarbon reserves. For further information, please visit the Company's website at http://www.petrogencorp.com.
THIS NEWS RELEASE MAY INCLUDE FORWARD-LOOKING STATEMENTS WITHIN THE MEANING OF SECTION 27A OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, AND SECTION 21E OF THE UNITED STATES SECURITIES AND EXCHANGE ACT OF 1934, AS AMENDED, WITH RESPECT TO ACHIEVING CORPORATE OBJECTIVES, DEVELOPING ADDITIONAL PROJECT INTERESTS, THE COMPANY'S ANALYSIS OF OPPORTUNITIES IN THE ACQUISITION AND DEVELOPMENT OF VARIOUS PROJECT INTERESTS AND CERTAIN OTHER MATTERS. THESE STATEMENTS ARE MADE UNDER THE "SAFE HARBOR" PROVISIONS OF THE UNITED STATES PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 AND INVOLVE RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE IN THE FORWARD-LOOKING STATEMENTS CONTAINED HEREIN.
Company Contact
Louis J. Fruchier
V.P. Corporate Development & Communications
Petrogen Corp.
888-875-1155
fruchier@petrogencorp.com
SOURCE Petrogen Corp.
Louis J. Fruchier, V.P. Corporate Development & Communications of Petrogen Corp.,
1-888-875-1155, fruchier@petrogencorp.com
http://www.prnewswire.com
Copyright (C) 2005 PR Newswire. All rights reserved.
Stockwire.com: The Movers and Shakers Blog:
MIAMI, Oct 17, 2005 (M2 PRESSWIRE via COMTEX) -- We like stocks trading big dollar value volume! A very interesting indicator to look for is where the money is flowing into. We have a filter that we watch every morning that shows us "Dollar Volume". We also like stocks that are trading at bargain prices. As of 10:30AM, a couple of these stocks are: (OTCBB: UPDA), (OTCBB: ACTC), (OTCBB: CHAR), (OTCBB: LLLI)
To feature your publicly traded company in our alerts, email us at getfeatured@stockwire.com
UPDA will operate call centers designed to be multimedia contact centers, able to facilitate computer telephony integration technology, thereby enabling all forms of Internet, cable and telephony commerce. For the 6 months ended 6/30/05, the Company reported no revenues. Net loss totaled $6.3M, up from $529K. Revenues reflect the absence of revenue generating activities, and $6.1M in consulting fees.
Advanced Cell Technology, Inc. (OTCB:ACTC) reported today the generation of embryonic stem cell lines using an alternative approach that does not interfere with the developmental potential of embryos. The research, which appears online (ahead of print) in the journal Nature, by ACT and its collaborators, describes a method of deriving stem cells in mice using a technique of single-cell embryo biopsy similar to that used in preimplantation genetic diagnosis (PGD) to test for genetic defects.
Chaparral Resources, Inc. is engaged in the exploration, development and production of oil and gas properties, currently focused on the Karakuduk Field in Kazakstan. For the 6 months ended 06/30/05, revenues rose 74% to $57.5M. Net income totaled $10.4M, up from $1.9M. Revenues reflect higher crude prices & increased sales volume. Net income also reflects increased interest income & improved operating margin.
Lamperd Less Lethal Inc. (OTCBB: LLLI) ("Lamperd") -- Mr Barry Lamperd, President and CEO is pleased to announce that Lamperd entered into an exclusive distributor agreement dated September 30, 2005 with Laser Shot, Inc., pursuant to which Lamperd was appointed the agent of Laser Shot, Inc. to promote and solicit orders of all products listed and described in Laser Shot's official catalogue, and to provide after-purchase support, on an exclusive basis in Canada. The Laser Shot Dynamic Simulator System is utilized for law enforcement and military training.
As a trader, a very intelligent place to put your money, is where the money is flowing into. When you get into stocks that are trading millions of dollars within the first 30-60 minutes of the market being open, chances are you will be able to get out of your position without hurting the stock. These are the kind of trades that you want to get into.
As the saying goes...follow the money!
To see the complete Movers & Shakers Blog go to: http://stockwire.com/blog.htm Stockwire.com is an online financial destination where investors can go to research new investment ideas. We are focused on finding emerging growth companies that do not necessarily have widespread analyst coverage on Wall Street. The site also provides investors with full coverage of quotes, charts, and news for all publicly listed stocks in the U.S.
Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on http://www.stockwire.com Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice. Reproduction without written permission is prohibited.
CONTACT: Stockwire Research Group, Inc. Tel: +1 305 476 1947 e-mail: info@stockwire.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web Inquiries to info@m2.com.
(C)1994-2005 M2 COMMUNICATIONS LTD
Vasomedical Reports First Quarter Fiscal 2006 Financial Results
Conference Call to Be Held Friday, October 14, 2005, at 10:00 AM, ET
WESTBURY, N.Y.--(BUSINESS WIRE)--Oct. 13, 2005--Vasomedical, Inc. (Nasdaq SC: VASO), a leader in the noninvasive treatment and management of cardiovascular diseases, today announced financial results for the three months ended August 31, 2005.
For the first quarter of fiscal 2006, Vasomedical recorded total revenues of $3.5 million, compared with total revenues of $4.8 for the first quarter of fiscal 2005. The Company reported a net loss of $0.9 million for the three months ended August 31, 2005, which was approximately equal to the net loss of $0.9 million in the year-ago quarter. For the quarter ended August 31, 2005, the Company recorded a $0.8 million preferred stock dividend reflecting beneficial conversion features related to the sale of convertible preferred stock on July 19, 2005. The total net loss attributable to common stockholders was $1.7 million for the quarter ended August 31, 2005, compared with a net loss attributable to common stockholders of $0.9 million for the quarter ended August 31, 2004. The net loss per common share was $0.03 per share for the first quarter of fiscal 2006, compared with $0.02 per share for the first quarter of fiscal 2005.
Thomas Glover, president and chief executive officer of Vasomedical, commented, "Although total revenue reflects a decline from the previous year's first quarter, we are encouraged that revenue of $3.5 million was fairly consistent with the previous three quarters despite a smaller sales force following the reorganization in May and the normally slower activity in the summer months. We believe the market will remain soft over the near term as many customers are delaying their purchases pending the Centers for Medicare and Medicaid Services (CMS) reimbursement coverage decision. Operating expenses, which are 26% lower than last year's first quarter are in line with our restructuring plan. Our overall strategy continues to be to attain our revenue goals through focused efforts in sales and marketing while maintaining tight expense control. At the same time, we are progressing toward our objective of expanding reimbursement coverage for EECP® therapy to include congestive heart failure patients as well as additional angina patients. We continue to communicate with CMS regarding their review of our recent application and with the lead investigators of the PEECH clinical trial regarding publication of results of this pivotal clinical study in a major peer-reviewed journal, which is a prerequisite for final CMS decision."
As of August 31, 2005, the Company had cash, cash equivalents and certificates of deposit balances of $3.5 million compared with $2.7 million as of May 31, 2005 and working capital as of August 31, 2005 of $5.3 million as compared with $3.9 million as of May 31, 2005.
Conference Call
The Company will host a conference call to discuss these financial results tomorrow beginning at 10:00 a.m. Eastern Time. To participate in the live call by telephone, please dial (800) 639-0297 from the U.S., or for international callers, please dial (706) 634-7417. A telephone replay will be available until 11:59 p.m. Eastern Time on October 16, 2005 by dialing (800) 642-1687 from the U.S. or (706) 645-9291 for international callers and entering pass code 1358470.
Those interested in listening to the conference call live via the Internet may do so by visiting the Company's web site at www.vasomedical.com, under the investor relations tab. To listen to the live call, please go to the web site 15 minutes prior to its start to register, download, and install the necessary audio software. The webcast will be archived for 30 days.
About EECP®Therapy
EECP external counterpulsation therapy is typically given in 35 one-hour sessions over seven weeks. Patients recline on a contoured treatment table and their calves, lower thighs and upper thighs are wrapped in a pneumatic cuff set. The system, which is synchronized to the individual patient's cardiac cycle, inflates the cuffs with air to create external pressure when the heart is resting and deflates the cuffs just before the next heartbeat. The system's action, which pulses counter to the heart's beating, increases blood flow to the heart muscle and other organs and decreases the heart's workload, creating a greater oxygen supply for the heart muscle while lowering its need for oxygen.
About Vasomedical
Vasomedical, Inc. is primarily engaged in designing, manufacturing, marketing and supporting EECP external counterpulsation systems based on the Company's unique proprietary technology. EECP therapy is a noninvasive, outpatient therapy for the treatment of diseases of the cardiovascular system currently indicated for use in cases of stable or unstable angina, congestive heart failure, acute myocardial infarction and cardiogenic shock. The therapy serves to increase circulation in areas of the heart with less than adequate blood supply and may restore systemic vascular function. The Company provides hospitals, clinics and private practices with EECP equipment, treatment guidance and a staff training and equipment maintenance program designed to provide optimal patient outcomes. Additional information is available on the Company's website at www.vasomedical.com. EECP is a registered trademark for Vasomedical's enhanced external counterpulsation systems.
Contact:
Vasomedical, Inc.
Thomas W. Fry, 516-997-4600
investorrelations@vasomedical.com
OR
Lippert/Heilshorn & Associates, Inc.
Kim Sutton Golodetz, 212-838-3777
kgolodetz@lhai.com
OR
Bruce Voss, 310-691-7100
bvoss@lhai.com
----------------------------------------
Source: Vasomedical, Inc.
Imaging Diagnostic Systems Reports Strong First Quarter Revenue
Record Five CTLM(R) Systems Sold
FORT LAUDERDALE, Fla., Oct 12, 2005 /PRNewswire-FirstCall via COMTEX/ -- Imaging Diagnostic Systems, Inc., ( IMDS ) reported today that a record five CT Laser Mammography (CTLM(R)) systems were sold in the quarter ending September 30, 2005.
In the quarter ending September 30, 2005, IDSI is expected to report net sales of $671,750, up from the $374,952 reported for the entire previous fiscal year ending June 30, 2005.
"Our first fiscal quarter was a clear endorsement of the effectiveness of our global commercialization program and growing market acceptance of laser breast scanning. Four of the five sales had been announced via press releases; details of the fifth will soon be released. We are gaining traction in several key geographic areas as our distributors and clinical partner sites gain experience with this new technology. It is an exciting time," stated Tim Hansen, IDSI Chief Executive Officer.
The CTLM(R) system is the first patented breast imaging system that utilizes state-of the-art laser technology and patented algorithms to create 3-D cross-sectional images of the breast. It is a non-invasive, painless examination that does not expose the patient to radiation or require breast compression. Imaging Diagnostic Systems has received CE Marking, CMDCAS (Canada), Canadian License, China SFDA approval, UL listing, ISO 9001:2000- 13488 certification and FDA export certification for its CT Laser Breast Imaging system. The Company is seeking PreMarket Approval (PMA) from the Food and Drug Administration (FDA) for its CTLM(R) system to be used as an adjunct to mammography.
Please visit Imaging Diagnostic Systems' website at: http://www.imds.com for additional information.
In conjunction with the provisions of the Safe Harbor section of the Private Securities Litigation Reform Act of 1995, this news release may contain forward-looking statements pertaining to future anticipated projected plans, performances and developments, as well as other statements relating to future operations. All such forward-looking statements are necessarily only estimates of future results and there can be no assurance that actual results will not materially differ from expectation. Further information on potential factors that could affect Imaging Diagnostic Systems, Inc., is included in the Company's filing with the Securities Exchange Commission.
Investor Relations:
Rick Lutz
404-261-1196
lcgroup@mindspring.com
SOURCE Imaging Diagnostic Systems, Inc.
Investor Relations, Rick Lutz, +1-404-261-1196, or lcgroup@mindspring.com, for
Imaging Diagnostic Systems
http://www.prnewswire.com
Copyright (C) 2005 PR Newswire. All rights reserved.
UGHO Insider bought 100,000 shares on October 6, 2005.
See Link:
http://yahoo.brand.edgar-online.com/fetchFilingFrameset.aspx?FilingID=3954112&Type=HTML
Vasomedical to Hold First Quarter Fiscal 2006 Financial Results Conference Call on October 14, 2005
WESTBURY, N.Y., Oct 11, 2005 (BUSINESS WIRE) -- Vasomedical, Inc. (NASDAQ SmallCap: VASO), will report financial results for the first quarter of fiscal 2006 on Thursday, October 13, 2005 after market close and will hold a conference call on Friday, October 14, 2005 at 10:00 a.m. Eastern Time to discuss these results. Thomas Glover, president and chief executive officer, and Thomas W. Fry, chief financial officer, will host the conference call.
To participate in the live call by telephone, please dial (800) 639-0297 from the U.S., or for international callers, please dial (706) 634-7417. A telephone replay will be available until 11:59 p.m. Eastern Time on October 16, 2005 by dialing (800) 642-1687 from the U.S. or (706) 645-9291 for international callers and entering passcode 1358470.
Those interested in listening to the conference call live via the Internet may do so by visiting the Company's web site at www.vasomedical.com. To listen to the live call, please go to the web site 15 minutes prior to its start to register, download, and install the necessary audio software. The call will be archived on the Company's web site for 30 days.
About Vasomedical, Inc.
Vasomedical, Inc. is primarily engaged in designing, manufacturing, marketing and supporting EECP(R) external counterpulsation systems based on the Company's unique proprietary technology. EECP therapy is a noninvasive, outpatient therapy for the treatment of diseases of the cardiovascular system currently indicated for use in cases of stable or unstable angina, congestive heart failure, acute myocardial infarction and cardiogenic shock. The therapy serves to increase circulation in areas of the heart with less than adequate blood supply and may restore systemic vascular function. The Company provides hospitals, clinics and private practices with EECP equipment, treatment guidance and a staff training and equipment maintenance program designed to provide optimal patient outcomes. Additional information is available on the Company's website at www.vasomedical.com. EECP is a registered trademark for Vasomedical's enhanced external counterpulsation systems.
Except for historical information contained in this release, the matters discussed are forward-looking statements that involve risks and uncertainties. When used in this report, words such as "anticipated," "believes," "could," "estimates," "expects," "may," "plans," "potential" and "intends" and similar expressions, as they relate to the Company or its management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Among the factors that could cause actual results to differ materially are the following: the effect of the dramatic changes taking place in the healthcare environment; the impact of competitive procedures and products and their pricing; medical insurance reimbursement policies; unexpected manufacturing or supplier problems; unforeseen difficulties and delays in product development programs; the actions of regulatory authorities and third-party payers in the United States and overseas; uncertainties about the acceptance of a novel therapeutic modality by the medical community; and the risk factors reported from time to time in the Company's SEC reports. The Company undertakes no obligation to update forward-looking statements as a result of future events or developments.
SOURCE: Vasomedical, Inc.
Vasomedical, Inc.
Thomas W. Fry, 516-997-4600
investorrelations@vasomedical.com
or
Investor Relations:
Lippert/Heilshorn & Associates, Inc.
Kim Sutton Golodetz, 212-838-3777
kgolodetz@lhai.com
Lisa Lindberg, 212-838-3777
llindberg@lhai.com
Bruce Voss, 310-691-7100
bvoss@lhai.com
Copyright Business Wire 2005
Petrogen's EH#3A Compression Initiative Completed
- Natural Gas Production Flow Rates Anticipated to Double -
HOUSTON, Oct 11, 2005 /PRNewswire-FirstCall via COMTEX/ -- Petrogen Corp. ( PTGC ) announced today that it has completed the installation of a two-stage compression system on its Emily Hawes #3A (EH#3A) natural gas discovery well, located on the Company's Emily Hawes Field property, Calhoun County, Texas.
On October 7th, 2005, crews were mobilized to Emily Hawes Field to install the compression system as part of Petrogen's ongoing developments upon its natural gas gathering and transportation management facilities on Matagorda Island. Increased natural gas flow from the EH#3A will initially be established over the course of the next several days utilizing one-stage of compression, at which time the Company will gauge consistent daily natural gas flow rates. Since the EH#3A well has been brought into production earlier this year, Petrogen has been receiving daily sales prices for its natural gas production from the well ranging between $10.00 per Mcfg up to as high as $17.95 per Mcfg.
Extensive analysis was performed by several natural gas compression specialists to determine gas flow rate increases that could be expected from the EH#3A through the addition of varying stages of compression. Results from the wellbore pressure and data analysis indicated that production flows from the EH#3A could be doubled with the implementation of one-stage of compression. Petrogen thereafter contracted Hanover Compression Company ( HC ) of Houston, Texas on August 30, 2005 to install a two-stage compression facility on the EH#3A well. Due to high line pressures on the Northern Natural Gas/Matagorda Offshore Pipeline System sales pipeline (NNG/MOPS), optimum daily natural gas production rates from the EH#3A have been suppressed. The addition of the first stage of compression has been implemented to mitigate any further suppression from the NNG/MOPS line pressures to ensure optimum daily natural gas flow rates can be sustained from the EH#3A.
On November 23, 2004, Petrogen announced that it successfully tested natural gas from the EH#3A well from the Basal Miocene M1 sand with an absolute open flow of 1,998 mcfgd; 978 mcfgd was tested on a 14/64" choke with flowing tubing pressure of 1,395 psi and a final shut-in pressure of 1,950 psi. On May 7, 2005, crews were mobilized to Emily Hawes Field and immediately began an extended production test of the EH#3A well. On August 3rd, 2005 Petrogen announced that it had commenced natural gas sales from the EH#3A well.
The Emily Hawes Field property is located approximately 90 miles southwest of Houston, Texas within the prolific oil and gas producing Miocene-Frio trend of the onshore and offshore Texas Gulf Coast. Near term plans include the expansion of operations through the development of a number of infill and step-out drilling locations to that of the EH#3A well targeted at the Basal Miocene Sands within the Emily Hawes Field.
About Matagorda Island
Matagorda Island is one of seven barrier islands located in the Gulf of Mexico, Texas Gulf Coast. Today, Texas and the Texas Gulf Coast represent one of the premier oil and gas exploration regions in the world, accounting for 32% of all natural gas production and 27% of proved natural gas reserves in the United States. Over the past few years, several large discoveries by Shell, BP and Chevron Texaco have contributed to the growing prominence of the Gulf Coast region as a hotbed for the expansion of domestic natural gas developments. Matagorda Island is approximately 34 miles long by 4 miles wide and is situated along the prolific, natural gas producing Miocene/Frio trend.
About Petrogen
Petrogen Corp. is a Houston, Texas based upstream energy company specializing in the development of natural gas properties in the Texas Gulf Coast region with known hydrocarbon reserves. For further information, please visit the Company's website at http://www.petrogencorp.com.
THIS NEWS RELEASE MAY INCLUDE FORWARD-LOOKING STATEMENTS WITHIN THE MEANING OF SECTION 27A OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, AND SECTION 21E OF THE UNITED STATES SECURITIES AND EXCHANGE ACT OF 1934, AS AMENDED, WITH RESPECT TO ACHIEVING CORPORATE OBJECTIVES, DEVELOPING ADDITIONAL PROJECT INTERESTS, THE COMPANY'S ANALYSIS OF OPPORTUNITIES IN THE ACQUISITION AND DEVELOPMENT OF VARIOUS PROJECT INTERESTS AND CERTAIN OTHER MATTERS. THESE STATEMENTS ARE MADE UNDER THE "SAFE HARBOR" PROVISIONS OF THE UNITED STATES PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 AND INVOLVE RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE IN THE FORWARD-LOOKING STATEMENTS CONTAINED HEREIN.
Company Contact:
Louis J. Fruchier
V.P. Corporate Development & Communications
Petrogen Corp.
888-875-1155
fruchier@petrogencorp.com
SOURCE Petrogen Corp.
Louis J. Fruchier, V.P. Corporate Development & Communications of Petrogen Corp.,
1-888-875-1155, fruchier@petrogencorp.com
http://www.prnewswire.com
Copyright (C) 2005 PR Newswire. All rights reserved.
Universal Guardian's Cobra StunLight(TM) Receives Notice of Allowance From U.S. Patent and Trademark Office
NEWPORT BEACH, Calif., Oct 06, 2005 /PRNewswire-FirstCall via COMTEX/ -- Universal Guardian Holdings, Inc. ( UGHO ), an emerging global leader in non- lethal protection products, integrated transportation security systems and strategic security services to protect against terrorist, criminal and security threats to governments and businesses worldwide, announced today that it received a Notice of Allowance from the United States Patent and Trademark Office for its Cobra StunLight(TM) flashlight. With the allowance of this patent application, Universal Guardian will be awarded exclusive protection for its Cobra StunLight(TM) which dispenses non-lethal substances, such as its ChemStream(TM) canisters, that are housed within the Cobra StunLight(TM). In addition to protecting its intellectual property rights in the United States, the company has filed for international patent protection for the Cobra StunLight(TM) under the Patent Cooperation Treaty.
According to Michael Skellern, Chief Executive Officer of Universal Guardian and co-inventor of the Cobra StunLight(TM) technology, "We're very excited about the U.S. Patent Office's Notice of Allowance as it grants Universal Guardian intellectual property protection for our aerosol dispensing Cobra StunLight(TM). Our Cobra StunLight(TM) offers defensive and offensive use-of-force options and provides law enforcement and security professionals with a 'True Non-lethal Alternative'(R) to other products and is an extremely cost-effective replacement to their standard flashlight, mace or pepper spray, and baton."
(Photo: http://www.newscom.com/cgi-bin/prnh/20050812/LAF021-a
http://www.newscom.com/cgi-bin/prnh/20050812/LAF021-b )
About Universal Guardian Holdings, Inc.
Universal Guardian Holdings, Inc. (UGHO) and its subsidiaries provide a comprehensive range of security products, systems, and services designed to mitigate terrorist and security threats worldwide. Universal Guardian Global Security Group comprises everything from strategic and tactical security services, business risk solutions, integrated and interoperable security systems, to non-lethal defense products. Universal Guardian companies features a wide variety of security applications for transportation and global supply chain security, maritime security and critical infrastructure protection for government and multi-national businesses on every continent. www.UniversalGuardian.com
About Shield Defense International
Shield Defense International (SDI), a wholly-owned subsidiary of Universal Guardian Holdings, Inc., designs and produces non-lethal weapons and systems that provide law enforcement, military, professional security and consumers with multiple use-of-force options to address appropriate threat conditions in today's growing global security and terrorist environments. www.ShieldDefense.com
ISR Systems, Inc. a wholly owned subsidiary of Universal Guardian Holdings, Inc., provides multi-level secure, security systems that facilitate surveillance, threat detection and tracking to protect inter-modal transportation, seaport and airport facilities, and critical infrastructure from asymmetrical terrorist and security threats. ISR turn key sourced-based SupplyChain Guardian(TM) RFID systems and Container Guardian(TM) systems provide increased supply chain efficiencies, visibility and security with automated monitoring and decision support from command and control centers in North America, Europe and Asia to coordinate notification to shippers, customers and tactical responses among multiple agencies to interdict or respond to potential security threats. www.ISRsystems.com
About Secure Risks Limited
SecureRisks, a wholly owned subsidiary of Universal Guardian Holdings, Inc, is a London based global security group providing practical risk solutions, tactical security products and services, and critical infrastructure protection in today's most challenging environments from regional hubs located in the United States, United Kingdom, Europe, South America, Middle East, Africa, Central Asia and Asia Pacific. www.SecureRisks.com
Safe Harbor Statement:
This news release contains certain forward-looking statements pertaining to future anticipated projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this news release that are not statements of historical fact may be considered to be forward-looking statements. Written words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including those detailed from time to time in Universal Guardian Holdings, Inc.'s reports filed with the Securities and Exchange Commission. There can be no assurance that actual results will not differ materially from expectations. These risks factors include potential customer interest in the sale and production of Cobra StunLight(TM) and Riot Defender(TM) and their accessories.
Further information is available on the Company's website: www.UniversalGuardian.com
Investor Relations Contact: Company Contact:
Investor Relations Michael J. Skellern
Universal Guardian Holdings, Inc. Chief Executive Officer
4695 MacArthur Court, Suite 300 Universal Guardian Holdings, Inc.
Newport Beach, CA USA 92626 4695 MacArthur Court, Suite 300
+ 1.949.861.8295 ext. 211 Newport Beach, CA USA 92626
+ 1.949.861.8295
SOURCE Universal Guardian Holdings, Inc.
Investor Relations, Universal Guardian Holdings, Inc., +1-949-861-8295 ext. 211, or
Michael J. Skellern, Chief Executive Officer of Universal Guardian Holdings, Inc.,
+1-949-861-8295
http://www.prnewswire.com
Copyright (C) 2005 PR Newswire. All rights reserved.
Lamperd Less Lethal Inc. Announces Signing of Geographic Exclusive Sales Agent Agreement
SARNIA, Ontario, Oct 05, 2005 (BUSINESS WIRE) -- Lamperd Less Lethal Inc. (OTCBB:LLLI) ("Lamperd") -- Mr. Barry Lamperd, President and CEO is pleased to announce that Lamperd entered into an exclusive distributor agreement dated September 30, 2005 with Laser Shot, Inc., pursuant to which Lamperd was appointed the agent of Laser Shot, Inc. to promote and solicit orders of all products listed and described in Laser Shot's official catalogue, and to provide after-purchase support, on an exclusive basis in Canada. The Laser Shot Dynamic Simulator System is utilized for law enforcement and military training.
In order to maintain these exclusive distribution rights in Canada, Lamperd must purchase and pre-pay at least $50,000.00 worth of Laser Shot's product per calendar quarter, adjusted annually. In addition, Lamperd may manufacture the Mobile Modular Shooting Range for Laser Shot. The modular range is used by police departments that have a need for a live fire training range but do not have the ability to upgrade their existing range or construct a new range. Lamperd must pay Laser Shot a licensing fee of 15% of the retail price of any modular range that Lamperd might elect to build. The agreement has an initial term of three years, and thereafter until terminated by either party on ninety days notice.
In addition, Lamperd confirms that it has received approval for the importation of its Defender launcher into the United States for sale. The Bureau of Alcohol, Tobacco and Firearms provided such approval, under license number 903050/ELG.
Forward-Looking Statements. This news release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such statements include, but are not limited to, any sales that may be generated pursuant to the agreement with Laser Shot, Inc. Such factors include, among others, the inherent uncertainties associated with the development of an early stage company in the firearms and munitions industry and its products and the entry into new markets for our products. These forward-looking statements are made as of the date of this news release, and Lamperd Less Lethal assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our periodic reports filed from time-to-time with the Securities and Exchange Commission.
SOURCE: Lamperd Less Lethal Inc.
CONTACT: Lamperd Less Lethal Inc.
Investor Relations, 519-344-4445
email: info@lamperdlesslethal.com
Copyright Business Wire 2005
-0-
KEYWORD: United States
Canada
North America
Nevada
INDUSTRY KEYWORD: Government
Defense
Law Enforcement
Manufacturing
Other Manufacturing
SUBJECT CODE: Contract/Agreement
Universal Guardian's Cobra StunLight(TM) Successfully Introduced at Convention of Mexico's Chiefs of Police and Mayors
NEWPORT BEACH, Calif., Oct 05, 2005 /PRNewswire-FirstCall via COMTEX/ -- Universal Guardian Holdings, Inc. ( UGHO ), an emerging global leader in non-lethal protection products, integrated transportation security systems and strategic security services to protect against terrorist, criminal and security threats to governments and businesses worldwide, successfully introduced the company's non-lethal Cobra StunLight(TM) to Mexico's police chiefs and mayors at the sixth National Convention of Public Security organized by Mexican Association of Municipalities in Mexico City.
(Photo: http://www.newscom.com/cgi-bin/prnh/20050812/LAF021-a
http://www.newscom.com/cgi-bin/prnh/20050812/LAF021-b )
Mexico's National Security Convention is attended by City Mayors, City Managers, City Councils, and Public Security and Civilian Protection Directors from Municipal, State and Federal governments throughout the country to introduce new products and programs for citizen security, crime prevention and emergency response through the inter-institutional coordination, strategic and operational planning, and application of new technologies.
"The general consensus of Police Chiefs and Mayors from around Mexico was that the Cobra StunLight(TM) was as an ideal security product which would enhance the safety of police officers in cities across Mexico and reduce injuries to suspects that they apprehend," stated Captain Dennis Cole (Ret) of Shield Defense.
"Due to the overwhelming response to the Cobra StunLight(TM) at our National Security Convention in Mexico City, we are planning to expand our order quantities and required inventory levels to meet this anticipated demand," stated Miguel Botello, Managing Director of Shield Defense distributor VICGI S.A. of Monterrey, Mexico. "For example, a national beer distributor with more than 7,000 trucks stated that he would like to equip all of his drivers with Cobra StunLights(TM) to protect their personnel, cash and cargo," continued Mr. Botello.
"Law Enforcement agencies and distributors in other international markets have been searching for safe and effective non-lethal use-of-force alternatives and are now discovering that the Cobra StunLight(TM) offers a "True Non-lethal Alternative" to potentially deadly less-lethal weapons currently on the market," stated Michael Skellern, Universal Guardian CEO.
The Cobra StunLight(TM) provides escalating offensive and defensive non-lethal options for law enforcement, military and security professionals by incorporating three extremely bright tactical lights into a single flashlight head enabling the user to illuminate the target, use the red-laser aiming device to cause a "pause in combat", and if required, debilitate one or more assailants by launching a high pressure stream of OC up to 21 feet.
About Universal Guardian Holdings, Inc.
Universal Guardian Holdings, Inc. (UGHO) and its subsidiaries provide a comprehensive range of security products, systems, and services designed to mitigate terrorist and security threats worldwide. Universal Guardian Global Security Group comprises everything from strategic and tactical security services, business risk solutions, integrated and interoperable security systems, to non-lethal defense products. Universal Guardian companies features a wide variety of security applications for transportation and global supply chain security, maritime security and critical infrastructure protection for government and multi-national businesses on every continent. www.UniversalGuardian.com
About Shield Defense International
Shield Defense International (SDI), a wholly-owned subsidiary of Universal Guardian Holdings, Inc., designs and produces non-lethal weapons and systems that provide law enforcement, military, professional security and consumers with multiple use-of-force options to address appropriate threat conditions in today's growing global security and terrorist environments. www.ShieldDefense.com
About Secure Risks Limited
SecureRisks, a wholly owned subsidiary of Universal Guardian Holdings, Inc, is a London based global security group providing practical risk solutions, tactical security products and services, and critical infrastructure protection in today's most challenging environments from regional hubs located in the United States, United Kingdom, Europe, South America, Middle East, Africa, Central Asia and Asia Pacific. www.SecureRisks.com
Safe Harbor Statement:
This news release contains certain forward-looking statements pertaining to future anticipated projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this news release that are not statements of historical fact may be considered to be forward-looking statements. Written words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including those detailed from time to time in Universal Guardian Holdings, Inc.'s reports filed with the Securities and Exchange Commission. There can be no assurance that actual results will not differ materially from expectations. These risks factors include potential customer interest in the sale and production of Cobra StunLight(TM) and Riot Defender(TM) and their accessories.
Further information is available on the Company's website: www.UniversalGuardian.com
Investor Relations Contact:
Investor Relations Department
Investor Relations
Universal Guardian Holdings, Inc.
4695 MacArthur Court., Suite 300
Newport Beach, CA USA 92626
+ 1 949.861.8295 ext. 211
Company Contact:
Michael J. Skellern, Chief Executive Officer
Universal Guardian Holdings, Inc.
4695 MacArthur Court, Suite 300
Newport Beach, CA USA 92626
+ 1 949.861.8295
SOURCE Universal Guardian Holdings, Inc.
Investor Relations, ext. 211, or Michael J. Skellern, Chief Executive Officer, of
Universal Guardian Holdings, Inc., +1-949-861-8295
http://www.prnewswire.com
Copyright (C) 2005 PR Newswire. All rights reserved.
Caesar, in addition to the dividends HQNT gives its shareholders, this is the ONLY stock I can point to in the entire world with at least .13 eps, under 40 million shares outstanding and no debt. The only reason HQNT is trading at .29/share today is the overdue financial reports. I can wait.
Xechem's Orphan Drug Status Approved for Its Sickle Cell Medicine in the European Union
NEW BRUNSWICK, N.J., Oct 04, 2005 (BUSINESS WIRE) -- Xechem International, Inc. ( XKEM ) Xechem International announced today that its wholly owned subsidiary, Xechem UK Ltd., has received Orphan Drug designation from the European Medicine Evaluation Agency (EMEA) for NIPRISAN (now known as NICOSAN(TM)/HEMOXIN(TM)), a phytopharmaceutical product that has shown efficacy in the treatment of Sickle Cell Disease. The designation covers all 25 countries that comprise the European Union. Similar Orphan Drug status was previously granted to Xechem by the U.S. Food and Drug Administration.
Dr. Ramesh Pandey, Xechem's Chairman & CEO said, "Obtaining Orphan Drug status for our Sickle Cell Disease product in both the European Union and the United States brings to Xechem substantial advantages and incentives which will help facilitate approval of the drug and make it easier for us to bring this important medicine to market. To have received these coveted designations from both the FDA and EMEA for a natural, herb-based product such as ours is particularly gratifying."
Significance of Orphan Drug Designation
The EMEA regulation on orphan medicinal products is designed to encourage companies to develop and market treatments for rare, life threatening medical conditions that affect less than five people in every 10,000 in the EU. In addition to granting the license holder protection from direct or generic competition for a period of ten years within the EU following drug approval, orphan drug status allows for regulatory assistance, reduced regulatory fees associated with applying for marketing approval, protocol assistance and scientific advice. Similar incentives, including seven years of marketing exclusivity, tax credits, and access to potential grant funding for non-clinical and clinical research, accompany orphan drug status in the U.S.
According to Dr. Pandey, "Given the virtual lack of commercially viable treatments for SCD in the United States and the EU, the multi-year exclusivity for NICOSAN(TM)/HEMOXIN(TM) could create a significant revenue producing opportunity for Xechem."
About Sickle Cell Disease
Sickle Cell Disease (SCD) is a devastating hereditary blood disorder, caused by an abnormal Hemoglobin called Sickle Hemoglobin, and is characterized by acute painful crises, organ damage, anemia and early death. SCD is particularly prevalent among people from sub-Saharan Africa. In Nigeria alone over 4 million people are afflicted with the disease and another 26 million are believed to be carriers of the sickle cell trait. It is estimated that more than one out of seven persons living on the African continent carry the sickle cell trait and over 18 million actually suffer with the disease worldwide.
About Xechem
Xechem International, Inc., is a development stage biopharmaceutical company focusing on anticancer, antiviral (including AIDS), antifungal, Sickle Cell Disease (SCD), antimalarial and antibacterial products from natural sources, including microbial and marine organisms. Xechem's mission is to bring relief to the millions of people who suffer from these diseases. Its primary focus is on the development of phytopharmaceuticals and other proprietary technologies including those used in the treatment of orphan diseases. Nearly all of Xechem's attention and resources are currently being directed toward the development and commercial launch of NICOSAN(TM)/HEMOXIN(TM), which has shown efficacy in the treatment of SCD.
Forward Looking Statements
This press release contains certain forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, which are intended to be covered by safe harbors created hereby. Such forward-looking statements involve known and unknown risks and uncertainties.
SOURCE: Xechem International, Inc.
Xechem International, Inc.
Stephen Burg, 707-425-8855
or
Xechem UK Ltd
J. Martin Biggs, +44 (0) 7710 039 721
Copyright Business Wire 2005